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i 
Abstract 
A major intracellular calcium (Ca2+) uptake pathway in excitable and non-excitable 
eukaryotic cells is store-operated Ca2+ entry (SOCE). Stromal interaction molecule-1 
(STIM1) is the key regulator of SOCE and responds to changes in endoplasmic reticulum 
(ER)-stored Ca2+ through luminal sensing machinery composed of EF-hand and SAM 
domains (EFSAM). EFSAM can undergo N-glycosylation at Asn131 and Asn171 sites; 
however, the exact molecular and functional effects of N-glycosylation are unclear. By 
establishing a site-specific chemical approach to covalently linking glucose to EFSAM and 
subsequently examining EFSAM biophysical properties, I found that this modification 
enhances STIM1 activation through localized structural perturbations, decreased Ca2+ 
binding affinity, reduced stability and enhanced oligomerization. Further, Ca2+ influx via 
SOCE in HEK293 cells co-expressing Orai1 and STIM1 was diminished when N-
glycosylation was blocked. Collectively, my data suggests that N-glycosylation enhances 
EFSAM response to ER Ca2+ depletion thereby augmenting the role of STIM1 as the 
ON/OFF regulator of SOCE. 
Keywords 
stromal interaction molecule-1, calcium, store-operated calcium entry, N-glycosylation, 
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1.1 Calcium 
 
Calcium ions (Ca2+) are essential for numerous intracellular signals that regulate a 
plethora of cellular processes and are necessary to maintain cellular homeostasis. For 
example, at the synaptic junction, Ca2+ triggers exocytosis within microseconds, whereas 
Ca2+ has to signal over minutes to hours to drive events such as transcription and cell 
proliferation (Berridge et al., 2003). Therefore, precise control of Ca2+ levels in the 
cytoplasm is crucial for mediating these important processes. Furthermore, recognizing how 
these different Ca2+ signaling systems work and studying the delicate balance between the 
production and removal of Ca2+ signals in the cytoplasm is important for understanding the 
basis for myriad processes in both health and disease (Berridge et al., 2003).  
While each cell type possesses unique Ca2+ signaling properties, most systems 
function by transient Ca2+ pulses generated from a combination of addition and removal of 
cytosolic Ca2+ (Figure 1.1). The release of Ca2+ into the cytoplasm can be derived either from 
internal cellular stores or the external medium. The endoplasmic reticulum (ER) is 
considered to be a major internal Ca2+ store (Berridge, 1993; Clapham, 1995) with Ca2+ 
levels maintained in the ~100-800 µM range. Release of Ca2+ from the ER lumen is mediated 
by Ca2+ itself or by other messengers, such as inositol 1,4,5-trisphosphate (IP3). For example, 
the activation of G-protein coupled receptors (GPCR) on the plasma membrane (PM) leads to 
the activation of phospholipases, in turn resulting in the metabolism of phosphatidylinositol 
4,5-biphosphate generating diacylglycerol and IP3. IP3 is a small diffusible molecule that 
binds to the IP3 receptor on the cytosolic side of ER membrane. IP3 receptor which is also a 
channel, opens upon stimulation causing the release of Ca2+ from the lumen and into the 
cytoplasm (i.e., ~0.1-1 µM) (Bootman et al., 2001; Berridge et al., 2003). 
3 
Figure 1.1. Schematic diagram of the Ca2+ signaling pathway and homeostasis. 
This diagram was modified from Berridge et al., 2003. Plasma membrane GPCRs, 
TCRs and RTKs are shown in green, labeled as R. Downstream of PM receptor 
activation, the second messenger IP3 binds to its receptor on the S/ER membrane 
depicted in blue. Binding of IP3 to the IP3 receptor causes efflux of Ca2+ from the S/ER 
lumen and depletion of this major intracellular Ca2+ store. The S/ER Ca2+ depletion 
activates PM Ca2+ channels (grey square) and Ca2+ influx from the extracellular space 
ensues in the process of SOCE. The process is fully reversible once the Ca2+ store in S/
ER lumen is replenished by the SERCA pump. Mitochondria also sequesters cytosolic 
Ca2+ quickly through a uniporter, and then released slowly for SERCA and Ca2+-
ATPase (PMCA) uptake. Most cytosolic Ca2+ are bound to buffers, whereas a small 
proportion binds to the effectors to mediate various cellular processes. When these 
signals are no longer needed nor present, Ca2+ is removed from the cells by various 
exchangers and pumps such as Na+/Ca2+ exchanger (NCX), PMCA, SERCA.       
SERCA ER/SR 
[Ca2+] = 100-800 µM 
Mitochondria 
[Ca2+] = 0.1-1 µM 
Cytoplasm 
[Ca2+] = 0.1-1 µM 
Extracellular Space 
[Ca2+] = ~1000 µM 
R 
Na+ Na+ 
IP3 
Uniporter 
Ca2+ 
Buffers 
Stimulus 
Ca2+ 
Ca2+ 
Ca2+ 
PMCA 
Ca2+ 
EFFECTORS 
Proliferation, Transcription, Metabolism, Contraction, Exocytosis  
SOCE 
Pathway 
NCX 
NCX 
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Although the ER lumen is a major intracellular Ca2+ store, it is only a limited and 
exhaustible source of Ca2+. Whereas local and acute increases in cytosolic Ca2+ may trigger 
many processes, many of them rely on prolonged cytosolic Ca2+ signals to elicit responses 
such as gene transcription and cell proliferation (Hogan et al., 2003). Therefore, for 
maintained increases in cytosolic Ca2+ levels, an influx of Ca2+ is required beyond what is 
capable of being sourced from the ER. The extracellular space represents an essentially 
inexhaustible source of Ca2+ (i.e., >1000 µM), which can facilitate maintained increases in 
cytosolic Ca2+. Thus, opening of Ca2+ channels on the plasma membrane can result in an 
influx of Ca2+ down a steep concentration gradient (Feske, 2007). Importantly, the uptake of 
Ca2+ from the extracellular space is needed not only to sustain elevated cytosolic Ca2+ levels, 
but also to prevent depletion of ER Ca2+ levels and to replenish the ER Ca2+ stores. One of 
the major pathways that regulates ER Ca2+ levels and facilitates extracellular space Ca2+ 
influx is the store operated Ca2+ entry (SOCE) pathway (Putney, 1986). 
 
1.2 Store operated Ca2+ entry (SOCE)  
1.2.1 Discovery of the SOCE pathway 
SOCE is a major Ca2+ entry pathway in excitable and non-excitable cells (Varga-
Szabo et al., 2011; Shaw & Feske, 2013). Starting from the discovery and appreciation for 
the role of Ca2+ as an intracellular signal over a century ago (Ringer, 1883), there was 
considerable interest on the sources of such cellular Ca2+ (Rasmussen, 1970; Janis & Triggle, 
1983), eventually leading to the conception of the SOCE model (Putney, 1986). The origin of 
the SOCE theory is associated with an investigation of the kinetics of the potassium (K+) 
permeability response in the parotid gland using a unidirectional isotope flux technique 
5 
 
(Putney, 1976). This experiment revealed increased K+ permeability in two phases: a 
transient phase followed by a sustained phase. Interestingly, Putney and his colleagues also 
found that in the absence of extracellular Ca2+, only the sustained phase was no longer 
present (Putney, 1976). Moreover, it was demonstrated that the initial transient response was 
dependent on Ca2+ from inside the cell, and it could only be restored by external Ca2+ via 
plasma membrane Ca2+ channels, and upon depletion of the internal Ca2+ store (Parod & 
Putney, 1978). It was only realized 8 years later that the influx of Ca2+ to restore the internal 
Ca2+ levels was not a direct consequence of the activation of the plasma membrane GPCRs, 
but rather it was a result of the depletion of the Ca2+ levels in the intracellular stores (Putney, 
1986).   
1.2.2 Molecular players mediating SOCE 
SOCE, also known as capacitative Ca2+ entry, occurs subsequently to the release of 
intracellular Ca2+ stores, thereby causing an influx of Ca2+ from the extracellular space into 
the cytoplasm. Specifically, decreases in ER luminal Ca2+ levels result in the interaction 
between ER- and PM-resident proteins, which open PM Ca2+ channels that facilitate influx of 
Ca2+ from the extracellular space, thus elevating cytosolic Ca2+ levels and 
replenishing/maintaining high levels of Ca2+ in the ER lumen (Putney, 1986). In addition to 
the previously mentioned GPCRs in section 1.1, there is large range of other PM receptors 
that lead to IP3 production and subsequently to the depletion of ER Ca2+ stores, such as T-cell 
receptors (TCR) (van Leeuwen & Samelson, 1999; Lucas et al., 2003) and receptor tyrosine 
kinases (RTK) (Clapham, 1995; Schlessinger, 2000) (Figure 1.1). Following the efflux, the 
decrease in Ca2+ levels within ER lumen is detected and signals are sent to the PM of the cell 
to open Ca2+ channels and allow external Ca2+ to move down the concentration gradient into 
the cytosol.  
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These Ca2+ ions not only elevate the cytosolic levels of Ca2+ but are also an important source 
for sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) pumps located on ER membrane to 
recycle Ca2+ back into the ER lumen. It is important to note that the ER is not only a source 
of Ca2+, but this organelle also carries out critical processes that are Ca2+ dependent such as 
protein folding, vesicle trafficking, initiation of apoptosis, and many others (Berridge, 2002).  
Although the concept of SOCE was first proposed in 1986, it was not until two 
decades later that the principal molecular players in this process were identified. Liou and 
colleagues generated small interfering RNAs (siRNAs) against 2,304 proteins with known 
human signaling domains identified in the National Center for Biotechnology Information 
database and used them to test their role in receptor triggered Ca2+ signals in HeLa cells 
(Liou et al., 2005). HeLa cells were stimulated with histamine, a GPCR ligand (Hill, 1990; 
Leurs et al., 1995), and thapsigargin (TG), a non-competitive SERCA pump inhibitor 
(Jackson et al., 1988; Lytton et al., 1991; Treiman et al., 1998), fura2., a small molecule 
fluorescent cytosolic Ca2+ indicator, was used to assess the peak of the cytosolic Ca2+ 
increase followed by the plateau (Liou et al., 2005). The observed plateau phase was due to 
maintenance of high cytosolic Ca2+ levels from the activated SOCE pathway. Knockdown of 
stromal interaction molecule (STIM) proteins that are involved in the SOCE pathway 
resulted in a near complete loss of the cytosolic Ca2+ plateau due to downregulation of the a 
vital molecular component of the SOCE pathway (Liou et al., 2005). STIM1 and STIM2 
siRNA transfected cells showed a significantly reduced plateau of cytosolic Ca2+ levels and 
the reduction of this level was detected following the same magnitude of initial Ca2+ peak 
(i.e., same level of transient Ca2+ release from the ER store). Interestingly, these two proteins 
had already been biochemically characterized to some extent even prior to the discovery of 
their link to SOCE. Specifically, STIM1 and STIM2 were known to contain a transmembrane 
7 
 
(TM) domain, an EF-hand Ca2+ binding domain, and were found to form homo- and hetero-
oligomers (Williams et al., 2001, 2002). Consequently, Liou et al. (2005) concluded that the 
two homologues, STIM1 and STIM2, must be the critical players of SOCE. 
An independent study by Roos and colleagues (Roos et al., 2005) investigated the 
essential players of the SOCE pathway in Drosophila S2 cells. They suppressed several 
targeted genes using RNA interference (RNAi), and by using TG and fura2, they discovered 
the Drosophila STIM orthologue protein was vital for mediating SOCE in this cell type. 
Furthermore, to distinguish which of the two mammalian homologues, STIM1 or STIM2, is 
responsible for SOCE, Roos and colleagues performed RNAi-mediated knockdown of 
human STIM1 in HEK293 and SH-SY5Y neuroblastoma cells over expressing STIM1 (Roos 
et al., 2005). In both cases, cells displayed reduced Ca2+ influx upon TG treatment. However, 
knockdown of STIM2 in these cells showed unaltered levels of Ca2+ influx. Therefore, Roos 
et al. (2005) concluded STIM1, a protein that is ubiquitously expressed and conserved from 
Drosophila to mammalian cells, is an essential molecular player in SOCE. 
In 2006, Prakriya and colleagues identified a protein called Orai1, a previously 
uncharacterized protein with four putative TM segments, to be involved in the SOCE 
pathway (Prakriya et al., 2006). They performed a pedigree analysis to identify the missense 
mutation in Orai1 leading to defective Ca2+ entry via SOCE associated with severe combined 
immunodeficiency disease (SCID) (Feske et al., 2006; Prakriya et al., 2006). Furthermore, 
other groups that conducted a genome-wide RNAi screen in Drosophila cells to identify the 
gene responsible for SOCE Ca2+ influx similarly identified the orthologue of human Orai1 
(Yeromin et al., 2006; Zhang et al., 2006a). Based on these early studies we now know that 
the identities of the molecules that mediate SOCE include the ER-inserted STIM proteins and 
the PM-resident Orai proteins. Importantly, it was found that co-overexpression of STIM1 
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and Orai1 results in very large increases (5-10-fold) in sustained cytosolic Ca2+ levels after 
ER lumen Ca2+ store depletion using TG, further reinforcing the role of STIM1 and Orai1 in 
the SOCE pathway (Mercer et al., 2006). Additionally, when STIM1 interacted with Orai1 
reconstituted in liposomes, a SOCE-like phenomenon was observed indicating that these 
proteins are the minimal requirements for SOCE (Gudlur et al., 2014).  
 
1.3 Stromal interaction molecule (STIM) and Orai  
1.3.1 STIM and Orai domain architectures 
After the discovery of STIM and Orai proteins as the principal molecular players of 
SOCE, determining the three-dimensional (3D) atomic resolution structure of these proteins 
was vital to understanding the precise mechanisms activating the SOCE pathway.  
1.3.1.1 STIM domain architectures 
STIM proteins are single-pass type I TM proteins and, in vertebrates, there are two 
homologues, STIM1 and STIM2. Although it was discovered that a small fraction of STIM1 
is located on the PM, STIM proteins are mainly localized to the ER membrane (Manji et al., 
2000; Williams et al., 2001; Zhang et al., 2005; Cai, 2007a). The ER lumen-oriented region 
of STIM is composed of EF-hand and sterile α-motif (SAM) domains, and immediately 
following the TM domain there are three coiled-coil (CC) domains located on the cytosolic 
side of the protein (Figure 1.2). A long CC1 is located closest to the TM domain followed 
immediately by two shorter CC domains (i.e., CC2 and CC3); further, proximal to the CC 
region are proline- and serine-rich regions and lysine-rich region near the C-terminus (Figure 
1.2) (Stathopulos & Ikura, 2013a). The sequence comparison of the two human STIM 
homologues as well as STIMs from lower to higher eukaryotes (Stathopulos & Ikura, 2013a), 
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reveals that the above mentioned domains are conserved, suggesting that they are vital to the 
function of STIM proteins across species.  
There are two human STIM homologues, STIM1 and STIM2 with 76% sequence 
identity (Stathopulos & Ikura, 2013a). Previously, more focus has been on studying STIM1 
as the regulator of SOCE pathway activation but both homologues play a major role in 
regulating Ca2+ homeostasis in the cell. STIM1 and STIM2 differ in of the manner in which 
they maintain optimal Ca2+ levels in the cell with STIM1 being the ON/OFF switch of SOCE 
and STIM2 directly involved in sustaining basal Ca2+ levels (Stathopulos & Ikura, 2013a). 
Both STIM1 and STIM2 proteins contain an ER localization sequence near the N-terminus. 
Whereas STIM1 contains a 22-residue ER signal peptide, STIM2 has an 87-residue insertion 
into this N-terminal region, resulting in a much longer ER signal peptide (Stathopulos & 
Ikura, 2013a). Interestingly, the longer signal peptide of STIM2 is believed to decrease its 
ER localization efficiency, resulting in a small fraction of the pre-protein found in the 
cytoplasm instead of inserted in the membrane. Furthermore, such cytosolic STIM2 pre-
protein is believed to regulate Orai1 in a Ca2+ store-independent manner, where it maintains 
basal Ca2+ levels and Ca2+-dependent transcription (Graham et al., 2011). STIM1 is 
expressed in most human tissues (Darbellay et al., 2011; Horinouchi et al., 2012). 
 
 
 
 
 
Figure 1.2. STIM1 domain architecture and sequence alignment. (A) STIM1 domain 
architecture. S indicates signaling peptide, cEF is the canonical EF-hand, nEF is the noncanonical 
EF-hand, SAM is the sterile alpha motif domain, and TM represents transmembrane domain. The 
relative positions of the Asn131 and Asn171 sites are shown as blue triangles above the domain 
positions. After the TM are three coiled coil domain (i.e., CC1-3), a proline and serine rich region 
(P/S) and a lysine rich region (poly-K) near the C-terminal domain. (B) Multiple sequence 
alignment of human and lower order STIM proteins. H. sapiens STIM1 (NCBI, NP_003147.2), H. 
sapiens STIM2 (NCBI, NP_065911.3), Caenorhabditis elegans STIM (NCBI, CCD73857.1), and 
Drosophila melanogaster STIM (NCBI, NP_523357.2) sequences were aligned using Clustal 
Omega (Sievers et al., 2011) with the default settings. The (*) indicates fully conserved residue, (:) 
strongly similar residues, and (.) weakly similar residue. Conserved residue regions are shaded to 
correspond with the domain color scheme in A; glycosylation sites are highlighted in cyan. 
(B) 
    H.sapiens1 -----------MDVCVRLALWLL------------------------------------WGLLL-----------------HQGQ---SL 23!
    H.sapiens2 --------------------MLV------------------------------------LGLLV-----------------AGAADGCEL 17!
     C.elegans ------------------------------------------------------------------------------------------ !
D.melanogaster MRKNTIWNYSLIFFCCVLKSISTLDHGPHTVSVDSNRHNTQHQYKQNPNVASQRHSSHESGQSLHNSQSEHVTHIAASHAGSGGEHSTHL 90!
                                                                                !
! ! ! ! ! ! ! ! Canonical EF-hand 
    H.sapiens1 S--HSHSEKA-TGTS---------SGANSEESTAAEFCRIDKPLCHS--EDEKLSFEAVRNIHKLMDDDANGDVDVEESDEFLREDLNYH 99!
    H.sapiens2 VPRHLRGRRA-TGSA-ATAASSPAAAAGDSPALMTDPCMSLSPPCFT--EEDRFSLEALQTIHKQMDDDKDGGIEVEESDEFIREDMKYK 103!
     C.elegans ---MGRVSWII-ALYLTINV--VIVV------NGDRVTRNVEVTAEEEKIRDKLGYEAIRDIHRDMDDDHSGSIDRNESTGFMKEDMQMR 78!
D.melanogaster AQNLHRSSYNLLSEAMSQAVSNEFSS--MGSGSADGACAADDFDCYSGSVQDRFGMEAIASLHRQLDDDDNGNIDLSESDDFLREELKYD 178!
                         :      .                        .  .      :::. **:  :*: :*** .* :: .**  *::*:::      !
! ! Noncanonical EF-hand                      SAM 
    H.sapiens1 DPTVKHS--TFHGEDKLISVEDLWKAWKSSEVYNWTVDEVVQWLITYVELPQYEETFRKLQLSGHAMPRLAVTNTTMTGTVLKMTDRSHR 187!
    H.sapiens2 DATNKHS--HLHREDKHITIEDLWKRWKTSEVHNWTLEDTLQWLIEFVELPQYEKNFRDNNVKGTTLPRIAVHEPSFMISQLKISDRSHR 191!
     C.elegans GSERTRRENKFHGDDDAITVDDLWEAWFESIERTWTNERLVEWLINDVNLPSIVEAVKAKKIDGKILPRFASPNSDFLNKELGIKSSVYR 168 !
D.melanogaster SGYEKRQKAFHFNDDMHISVKELWEAWLRSEVHNWTIEQTTDWLAQSVQLPQYVDLFKLHKVTGAALPRLAVNNLQYVGNVLGIKDPIHK 270!
                   .:     . :*  *::.:**: *  *   .** :   :**   *:**.  . .:  :: *  :**:*  :     . * :..  ::!
!       TM                     Putative coiled-coil 1 
    H.sapiens1 QKLQLKALDTVLFGPPLLTRHNHLKDFMLVVSIVIGVGGCWFAYIQNR-YSKEHMKKMMKDLEGLHRAEQSLHDLQERLHKAQEEHRTVE 276!
    H.sapiens2 QKLQLKALDVVLFGPLTRPPHNWMKDFILTVSIVIGVGGCWFAYTQNK-TSKEHVAKMMKDLESLQTAEQSLMDLQERLEKAQEENRNVA 280!
     C.elegans QKLRLNSLDVVLFGYKDNN--NRTKDILLAFLAL-LLTSLIFLYVRQKQKAQQKVNELSNKLTELKCMETEFEDVQKMLNDERSK----- 250!
D.melanogaster QKISLKAMDVVLFGPPRETGTRW-KDYILVTLLLSAIIGCWYAYQQNK-NAKRHLRRMAQDMEGLQRAEQSLQEMQKELERARMEQENVA 356!
               **: *:::*.****       .  ** :*.   :  : .  : * :::  ::.:: .: :.:  *:  * .: ::*: *.  : :     !
! ! ! ! Putative coiled-coil 1             Coiled-coil 2!
    H.sapiens1 VEKVHLEKKLRDEINLAKQEAQRLKELREGTENERSRQKYAEEELEQVREALRKAEKELESHS-SWYAPEALQKWLQLTHEVEVQYYNIK 365!
    H.sapiens2 VEKQNLERKMMDEINYAKEEACRLRELREGAECELSRRQYAEQELEQVRMALKKAEKEFELRS-SWSVPDALQKWLQLTHEVEVQYYNIK 369!
     C.elegans ------------------------RSI--------SDGVVNHTEMENLRVQLEEAERRLEANSNGSQAPLALQPLLRRTCENEMAFLEKQ 308!
D.melanogaster TEKLDLERRLKEAPTLSSSNSD-------------LEVQQLKKEIEMLRNELSRAEFEL-VDN-CWSPPPQLQSWLQYTYELESKNHQKK 431!
                                                        . *:* :*  * .** .:   .     *  **  *: * * *    : :!
! !       Coiled-coil 2         Coiled-coil 3!
    H.sapiens1 KQNAEKQLLVAKEGAEKIKKKRNTLFGTFHVAHS--SSLDDVDHKILTAKQALSEVTAALRERLHRWQQIEILCGFQIVNNPGIHSLVAA 453!
    H.sapiens2 RQNAEMQLAIAKDEAEKIKKKRSTVFGTLHVAHS--SSLDEVDHKILEAKKALSELTTCLRERLFRWQQIEKICGFQIAHNSGLPSLTSS 457!
     C.elegans RQDCFKEMKEAIEMVDRLQKKQGSVLSSLKLATGAASTSDQVDSKIFALKSRMEKIHTLTRETQERWLQIESLCGFPLLYLNETEHINRS 398!
D.melanogaster RTSAEKQLQSAREACEKLRKKRSSLVGAFVSTHG--KSIDDVDRSIVEARNALGDVTNELQERLHRWKQIETCLGLNIVNNNGLPYLENV 519!
               : ..  ::  * :  ::::**: ::..::  : .  .: *:** .*.  :. : .:    :*   ** ***   *: :        :   !
!
    H.sapiens1 LNIDPSW----MGSTRPNPAHFIMTDDVDDMDEEIVS-PLSMQSPSLQSSVRQRLTEPQHGLGSQRDLTHSDSESSLHMSDRQRVAPKPP 538!
    H.sapiens2 LYSDHSW----VVMPRVSIPPYPIAGGVDDLDEDTPP-IVS-QFP-------GTMAKPPGSLARSSSLCR----------SRRSIVPSSP 524!
     C.elegans IASSHFYNKSHEGSSSSGS----ISNAH------SNPNAVNSNFV------------------------------------KKVSPPIPP 442!
D.melanogaster LYGRNGGLQSSMGMSSTKGSRARITNSTEDLDDESIQGKLNFENFSLLATE--------------------------------------- 570!
               :                      ::              :. :                 !
!
    H.sapiens1 QMSRAADEALNAMTSNGSHRLIEGVHPGSLVEKLP------DSPALAKKA------LL----------------ALNHGLDKAH----S- 595!
    H.sapiens2 QPQRAQLAPHAPHPSHPRHPHHPQHTPHSLPSPDPDILSVSSCPALYRNEEEEEAIYFSAEKQWEVPDTASECDSLNSSIGRKQSPPLSL 614!
     C.elegans SQQTANL---RFVPTEQSDSIHSEDT-------SPIVEDVAISRSLTQDLAEAD-------MQ-----------SIVSGS---------- 494!
!
!
    H.sapiens1 --LMELSPSAPPGGS-PHLDSSRSHSPSSPDPDT--PSPVGD------------------------------------------------ 632!
    H.sapiens2 EIYQTLSPRKISRDEVSLEDSSRGDSPVTVDVSWGSPDCVGLTETKSMIFSPASKVYNGILEKSCSMNQLSSGIPVPKPRHTSCSSAGND 704!
     C.elegans ---------TNGSGSVAALKKRKGIFPKLFRRNTSKSSSLGGTSN--------------------------------------------- 530!
!
! ! ! ! ! !     Poly-K 
    H.sapiens1 SRALQ----ASRNTRIPHLAGKKAVAEEDNGSIGEETDSSPGRKKFPLKIFKKPLKK 685!
    H.sapiens2 SKPVQEAPSVARISSIPHDLC----------HNGEKS-KKPSKI---KSLFKKKSK- 746!
S poly-K nEF cEF TM CC1 CC2 CC3 P/S N C SAM 
Luminal side Cytosolic side 
(A) 
Asn131 Asn171 
23                     63    96     127 132      200           234                    343 345         391 393        473          600       629   672                   
10 
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1.3.1.2 Orai domain architectures 
Orai proteins are PM-localized and are predicted to contain four TM domains; 
further, there are three human homologues, Orai1, Orai2, and Orai3 (Cai, 2007b). The three 
types of human Orai homologues share conserved primary sequence including specific 
residues responsible for dictating the channel characteristics, such as ion permeability, ion 
selectivity, and formation of a hydrophobic gate (Stathopulos & Ikura, 2013a). Moreover, 
both N- and C-termini face the cytoplasm and are believed to play a role in the interaction 
with STIM1 that mediates channel assembly and gating (Stathopulos & Ikura, 2013a). TM 
segment 1 (TM1) was identified to line the Ca2+ permeation pore within the Ca2+ channel, 
and Glu106 of TM1 and Glu190 of TM3 were found to form the Ca2+ binding site and 
provide Ca2+ selectivity, respectively (Prakriya et al., 2006; Yeromin et al., 2006). Similar to 
STIM proteins, different Orai proteins of lower order eukaryotes contain highly conserved 
TM regions and loop regions located between TMs. All Orai human homologues, when 
exogenously expressed have successfully formed functional Ca2+ released activated Ca2+ 
(CRAC) channels (Dehaven et al., 2007; Gwack et al., 2007; Lis et al., 2007; Frischauf et al., 
2009; Bogeski et al., 2010). However, the three homologues differ in sensitivity to Ca2+-
dependent inactivation (Lis et al., 2007) and even though Orai1, Orai2, and Orai3 are all 
widely expressed across human tissues (Gwack et al., 2007; Schindl et al., 2009), 
endogenous CRAC channels are only formed by the homomeric assembly of Orai1 proteins 
(Mignen et al., 2008; Hou et al., 2012; Thompson & Shuttleworth, 2013). It is still unclear 
how many Orai1 subunits are required to make a CRAC channel, and the two leading 
possibilities for the functional stoichiometry are hexamer or tetramer (Mignen et al., 2008; 
Hou et al., 2012; Thompson & Shuttleworth, 2013).  
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1.3.2 STIM1 and Orai1 in the activation of SOCE 
The activation of SOCE involving STIM1 and Orai1 proteins is a multistep process 
(Figure 1.3). The pathway is initiated by the response of STIM1 to ER Ca2+ levels. As 
mentioned above, STIM1 acts as the ER luminal Ca2+ sensor, and the luminal domain 
contains a canonical Ca2+ binding EF-hand motif (Roos et al., 2005; Liou et al., 2005; 
Stathopulos et al., 2006). When the Ca2+ levels in the ER are at rest (i.e., ~400-800 µM), Ca2+ 
ions are normally bound to the canonical EF-hand motif of STIM1. However, upon decreases 
in ER luminal Ca2+ levels (i.e., ~100-400 µM) and a loss in the EF-hand Ca2+ binding, a 
structural change occurs in the STIM1 luminal domain that initiates oligomerization of the 
protein. The oligomerization of the STIM1 luminal domain induces structural changes in the 
cytosolic region of STIM1 that enhances the oligomerization of the molecule. The 
oligomerized STIM1 subsequently translocates to ER-PM junctions, forming puncta. At ER-
PM junctions, oligomerized STIM1 recruits Orai proteins to the same punctate aggregates 
(Liou et al., 2005, 2007; Zhang et al., 2005). Puncta formation was shown using total internal 
reflective fluorescence (TIRF) microscopy in HeLa and HL1 cardiomyocyte cells co-
expressing monomeric cherry tagged (mCh)-STIM1 and enhanced green fluorescence protein 
(eGFP)-Orai1 (Stathopulos et al., 2013). At resting ER Ca2+ levels, mCh and eGFP 
fluorescence is pervasive along the ER membrane and PM, respectively. However, when TG 
passively depletes the ER Ca2+ store, there is an accumulation of the fluorescence signal at 
ER-PM junctions, indicating puncta formation and the co-localization of STIM1 and Orai1 
proteins within ~100 nm of the surface of the cell (Stathopulos et al., 2013). STIM1 
assembles Orai proteins into open CRAC channels within these puncta at ER-PM junctions, 
thereby mediating Ca2+ influx from the extracellular space.  
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Figure 1.3. Schematic diagram of the SOCE molecular activation mechanism. 
Decreases of ER luminal Ca2+ levels initiates EFSAM oligomerization. Oligomerization 
promotes rearrangement of the coiled-coil domains that promotes translocation of STIM1 
to ER-PM junctions. The STIM1 puncta at ER-PM junctions recruit Orai1 to the same sites, 
assembling and opening CRAC channels that promote cytosolic Ca2+ influx down a steep 
concentration gradient from the extracellular space that contains high Ca2+ into the cytosol.  
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1.4 STIM1 luminal domain 
1.4.1 STIM1 luminal domain structure  
The STIM1 luminal domain has conserved EF-hand and SAM domains close in 
sequence space that fold cooperatively into a single globular domain. Therefore, this region 
is also known as the EFSAM domain of STIM1. The EFSAM domain is highly conserved 
from lower to higher functioning eukaryotes. The human STIM1 EFSAM domain includes 
residues 63 to 201 and consists of a canonical Ca2+ binding EF-hand (cEF) motif, a non-
canonical EF-hand (nEF) motif and a SAM domain. Stathopulos and his colleagues 
discovered that an EFSAM mutant consisting of residues 58 to 201 contained a high fraction 
of α-helical secondary structure in the presence of Ca2+ and showed a well-dispersed 1H-15N 
heteronuclear single quantum coherence (HSQC) spectrum, indicative of a well-folded 
protein (Stathopulos et al., 2006, 2008).  
Based on primary sequence, the cEF motif was identified as the only EF-hand in 
STIM1 because of a conventional helix-loop-helix motif characteristics and the appropriate 
negatively charged residues in the loop (Kretsinger & Nockolds, 1973). However, the high 
resolution 3D structure solved by solution nuclear magnetic resonance (NMR) revealed that a 
second EF-hand was present in EFSAM (Stathopulos et al., 2008). This was an important 
discovery since the cEF was considered to be functioning as a stand-alone Ca2+ binding 
domain (Williams et al., 2001; Roos et al., 2005; Liou et al., 2005; Zhang et al., 2005; Baba 
et al., 2006; Mercer et al., 2006) prior to the elucidation of the EFSAM structure. 
Furthermore, it was found that one important role of the nEF motif is to stabilize cEF through 
backbone hydrogen (H)-bonding between the loop regions of each motif, creating a small β-
sheet as observed in other conventional cEF pairs such as calmodulin (CaM) (Ikura et al., 
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1985; Stathopulos et al., 2008). CaM is made up of two EF-hand domains linked through a 
flexible linker, and each of these domains is made up of two cEF motifs (Ikura et al., 1985; 
Chin & Means, 2000). Ca2+-loaded CaM has interhelix EF-hand angles of 81.4° and 107.7° 
indicative of an “open” EF-hand motif conformation; the cEF (α1-β1-α2) and nEF (α3-β2-
α4) of EFSAM also adopt this “open” conformation with approximately perpendicular 
interhelix angles of ~80° and 96.7° (Stathopulos et al., 2008). This feature of EF-hand 
domains results in the formation of a hydrophobic pocket that promotes interactions with 
target proteins. In the case of EFSAM, the SAM domain intramolecularly interacts with this 
extensive hydrophobic area created by the STIM1 EF-hand pair (Stathopulos et al., 2008). 
There is a cooperative interaction between the STIM1 EF-hand and SAM domains of 
STIM1 (Figure 1.4). The EF-hand domain is linked to the SAM domain with a short helix 
(α5), and the SAM domain consists of five helices (α6-α10) folded in a five-helix bundle 
(Stathopulos et al., 2008). The hydrophobic pocket created by cEF and nEF allows the α10 
helix of the SAM domain to tightly pack into this pocket forming a compact globular shape 
overall (Stathopulos et al., 2008). Thus, the EF-hand and SAM domains are not only linked 
in sequence space through α5, but they also interact through regions that are distant in 
sequence space. The intramolecular interaction between EF-hand and SAM domain is an 
important structural feature that plays an essential role in the regulation of STIM1 activation 
and function in the SOCE pathway. 
 
 
 
Figure 1.4. Depiction of the backbone structure of the Ca2+-loaded EFSAM domain. 
The EF-hands are coloured blue, the SAM domain is coloured green and the short linker 
helix is coloured yellow. Ca2+ is represented as a black sphere; N, amino terminus; C, 
carboxy terminus. The two asparagine residues, Asn131 and Asn171, are highlighted as red 
and magenta sticks, respectively. The Asn131 and Asn171 residues undergo N-linked 
glycosylation (see below). 
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1.4.2 Biophysical properties of STIM1 luminal domain  
The initial step of the SOCE pathway starts with the depletion of ER Ca2+ levels. 
Under resting ER Ca2+ levels, the STIM1 luminal EFSAM domain is bound to Ca2+ 
(Stathopulos et al., 2006; Stathopulos & Ikura, 2013b). With the cEF coordinating Ca2+, the 
EF-hand and SAM domains are well folded, forming the stable and compact monomeric 
conformation within STIM1 described above (Stathopulos et al., 2006, 2008). However, in 
the absence of Ca2+, this region loses a large fraction of its α-helicity and is drastically 
destabilized (Stathopulos et al., 2006, 2008). Dissociation of Ca2+ from the cEF binding site 
triggers an EFSAM unfolding event. This partial protein unfolding is coupled with a 
decreased stability and results in oligomerization of the STIM1 luminal domains. The 
EFSAM oligomers are polydisperse, consisting of dimers and larger order oligomers. STIM1 
oligomerized through the luminal domains results in a rearrangement of the cytosolic 
domains, oligomerization of the CC regions and translocation to the ER-PM junctions, 
establishing puncta. Thus, luminal EFSAM STIM1 oligomerization is the initiation event that 
leads to STIM1 translocation, recruitment and gating of Orai1 channels at ER-PM junctions, 
resulting in open CRAC channels on the PM ( Zhang et al., 2005; Stathopulos et al., 2006, 
2008; Liou et al., 2007).  
Assessment of EFSAM Ca2+ binding using a 45Ca2+ equilibrium ultrafiltration 
procedure and positive electrospray ionization mass spectrometry revealed a single low 
affinity Ca2+ binding site with an equilibrium dissociation constant (Kd) of ~200-600 µM 
(Stathopulos et al., 2006; Huang et al., 2009; Zheng et al., 2011). Furthermore, this Kd range 
is consistent with the physiological range of Ca2+ concentrations found in the ER lumen, 
suggesting that the EFSAM Ca2+ binding property is optimized to the Ca2+ fluctuations of the 
lumen for the regulation of SOCE.  
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1.5 N-glycosylation of STIM1    
In eukaryotes, most proteins undergo post-translational modifications for an added 
layer of protein regulation and selective participation in cellular processes (Walsh et al., 
2005; Boscher et al., 2011). A common modification is glycosylation where there is an 
attachment and processing of oligosaccharide structures, also known as glycans, through 
various biosynthetic steps in the ER and Golgi (Dennis et al., 2009; Nilsson et al., 2009; 
Stanley, 2011). The process of glycosylation can distinctly be separated into two types: N-
linked and O-linked glycosylation based on specific amino acid and linkage it forms.  
1.5.1 N-linked glycosylation 
In N-linked glycosylation, glycans are attached to the side chain amide of asparagine 
(Asn), and in most cases, the initiation step occurs in the ER as the polypeptide chain moves 
into the lumen and is still being translated outside the membrane; therefore, it is sometimes 
considered a co-translational modification (Gerlach et al., 2012). On the other hand, O-linked 
glycosylation refers to the addition of glycans on the side chain hydroxyl group of serine or 
threonine residues, and this modification occurs entirely after translation in the Golgi 
complex (Gerlach et al., 2012). The consensus amino acid sequence needed in the nascent 
polypeptide chain for N-linked modification is Asn-X-Ser/Thr/Cys, where X can be any 
amino acid except proline. When this sequence is recognized, the first step is the transfer of a 
fourteen-sugar structure made up of glucose (Glc), mannose (Man), and N-acetylglucosamine 
(GlcNAc) (i.e., Glc3Man9GlcNAc2) from an ER membrane lipid by oligosaccharyltransferase 
(Pearse & Hebert, 2010; Stanley et al., 2014). Further steps, such as cleavage or transfer of 
glucose residues, are catalyzed in the ER by specific glycosidases and glycosyltransferases. 
During modification in the ER, there are specific proteins such as UDP-glucose:glycoprotein 
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glucosyltransferase, that monitor proper protein folding upon glucose cleavage prior to 
further modification steps (Gerlach et al., 2012). Some proteins that are properly folded 
successfully leave the ER and move into the Golgi, and in the Golgi, a mannose subunit is 
removed to generate Man8GlcNAc2 to prevent further glucosylation (Avezov et al., 2008).  
1.5.2 N-glycosylation of EFSAM 
Examination of the EFSAM primary amino acid sequence reveals two consensus N-
linked glycosylation sites: Asn(residue 131)-Trp-Thr and Asn(residue 171)-Thr-Thr (Figure 
1.2). Further, previous studies have indeed shown that the EFSAM domain can be N-
glycosylated on Asn131 and Asn171 (Williams et al., 2002; Csutora et al., 2008; Kilch et al., 
2013). The first study by Williams and colleagues (Williams et al., 2002) found that a 
fraction of STIM1 is localized to the PM, where the EFSAM domain is oriented in the 
extracellular space. Furthermore, they discovered that inhibition of N-glycosylation using 
tunicamycin prevented STIM1 localization to the PM. Williams and coworkers also showed 
that both N-linked glycosylation of Asn131 and Asn171 were endoglycosidase H (endoH)-
sensitive (Williams et al., 2002). EndoH is an enzyme that digests glycans and is commonly 
used to study N-glycosylated proteins. EndoH cleaves the chitobiose core dimer of β-1,4-
linked GlcNAc in high mannose and some hybrid oligosaccharides that are modified in the 
Golgi, but is unable to cleave fully Golgi processed proteins with complex glycans. 
Therefore, the findings by Williams et al., on the endoH sensitivity of STIM1 indicates the 
immature modification and the absence of full terminal processing in the Golgi is sufficient 
for cell surface expression of STIM1 (Williams et al., 2002). Other STIM1 glycosylation 
studies by Csutora and Kilch and coworkers will be discussed below.  
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1.6 Rationale, hypothesis, and objectives  
1.6.1 Rationale and hypothesis  
While it is established that STIM1 has two N-glycosylation sites within the ER 
luminal region (i.e., the Asn131 site located in the short linker α-helix between the EF-hand 
and SAM domain and the second Asn171 site located within the SAM domain) the precise 
effect of N-glycosylation on the activation and function of STIM1 is unknown. Further, there 
are several ambiguous and inconsistent observations in the available literature on how N-
glycosylation may affect SOCE (Mignen et al., 2007; Csutora et al., 2008; Czyz et al., 2009; 
Kilch et al., 2013). A study by Czyz and colleagues found SOCE activity is enhanced in 
tunicamycin treated Jurkat cells. Tunicamycin inhibits endogenous glycosylation of all 
proteins; moreover, measurement of cytosolic Ca2+ concentrations with fura2 showed 
enhanced SOCE in tunicamycin treated Jurkat cells (Czyz et al., 2009). In a separate study, 
Kilch and colleagues, mutated the Asn131 and Asn171 of STIM1 to aspartic acid and 
glutamine (Gln), respectively, and found enhanced SOCE (Kilch et al., 2013). However, 
when they mutated both residues to Gln, SOCE was abolished. Mignen et al., also studied the 
effect of Asn to Gln double mutations in STIM1, but in contrast to the Kilch et al., study they 
found that the Asn131Gln/Asn171Gln double mutant had no effect on CRAC channel 
function using electrophysiological measurements (Mignen et al., 2007). On the other hand, 
work done by Csutora and coworkers showed that the Asn131Gln/Asn171Gln STIM1 double 
mutant inhibits SOCE (Csutora et al., 2008). Csutora et al., transfected the double mutant 
STIM1 into neuronal NG115 cells that endogenously express very low levels of STIM1 and 
found that SOCE was suppressed compared to the wild-type STIM1-mediated process 
(Csutora et al., 2008).  
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The published inconsistencies on how STIM1 N-glycosylation affects STIM1 
function reveal a pressing need to study the precise effect of glycosylation on EFSAM at the 
molecular and atomic levels. Since the initiation of the STIM activation process is entirely 
dependent on the EFSAM domain, a comparison of the structural, biophysical and 
biochemical changes caused by glycosylation of EFSAM should reveal how this 
modification affects STIM1 regulation of SOCE. Therefore, my thesis work focuses on how 
glycosylation affects the Ca2+ sensing properties of STIM1 EFSAM. I hypothesize that 
glucose conjugation to the STIM1 EFSAM domain at the Asn131 and/or Asn171 sites (i.e., 
neo-glycosylation) will alter the molecular properties of EFSAM as well as normal SOCE 
regulation.  
1.6.2 Objectives  
Aim 1: To express and purify recombinant wild type and mutant EFSAM proteins for site-
specific neo-glycosylation. 
I mutated Asn131 and Asn171 to cysteine (Cys) within an EFSAM recombinant expression 
vector to enable an enzyme-free in vitro approach for site-specifically controlling 
modifications at these sites. Cysteine residues have a thiol group that allows 
methanethiosulfonate-derivatized glucose to be covalently attached to the protein via 
disulfide bond formation. Glucose conjugation to the protein in this manner mimicked 
endogenous glycosylation with respect to the proximity of a glucose moiety close to the 
surface of the protein.  
 
Aim 2: To study the effect of neo-glycosylation on the structure, stability, oligomerization, 
and Ca2+ binding properties of the EFSAM domain. 
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STIM1 structure is highly dynamic and its biophysical properties are intimately linked to its 
activation. Therefore, examining the neo-glycosylation-induced changes in structure, 
stability, oligomerization and Ca2+ binding affinity provides a better understanding of the 
mechanisms by which glycosylation regulates STIM1 activity and the SOCE pathway. 
 
Aim 3: To examine the role of Asn131 and Asn171 glycosylation in STIM1 activated SOCE 
using HEK293 mammalian cell culture.  
I overexpressed mCh-tagged STIM1 with Asn131Gln, Asn171Gln or Asn131Gln/Asn171Gln 
mutations in HEK293 cells that were stably expressing YFP-Orai1. The mutations to Gln 
were engineered to block endogenous glycosylation at these sites within STIM1 without 
dramatically altering the polypeptide properties due to the similar nature of the Asn and Gln 
side chains. HEK293 mammalian cells are a good model system because this cell line 
expresses little or no STIM1 and Orai1 (Williams et al., 2001; Roos et al., 2005; Dehaven et 
al., 2007). The STIM1 activated cytosolic Ca2+ uptake in response to ER-luminal Ca2+ 
depletion by TG was studied using a fura2 ratiometric fluorescence approach. 
  
23 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2 Chapter 2 
Methods 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
24 
 
2.1 Constructs and Mutations 
The human STIM1 Ca2+ sensing domain corresponding to residues 58-201 was 
expressed in Escherichia coli using the previously described pET-28α-EFSAM vector 
(Stathopulos et al., 2006). The two asparagine residues (i.e., Asn131 and Asn171) were 
mutated to cysteines with High-Fidelity PCR polymerase (Thermo Scientific, Inc.), and 
mutagenic primers (Table 2.1). Two separate PCR mixtures, each with forward or reverse 
primers, were prepared and templates were amplified according to a 10-cycle mutagenesis 
program (Table 2.2). When 10 cycles were complete, the two separate PCR reactions were 
immediately mixed and amplified 25 additional cycles, using the same program (Table 2.2). 
After amplification was completed, the template vector was digested using DpnI (New 
England BioLabs, Inc.) for 2 h at 37 °C. The amplified DNA was subsequently transformed 
by heat shock into competent E. coli DH5α to repair the nicks and propagate the plasmid. 
Colonies harboring the mutated pET-28α-EFSAM plasmid were selected on kanamycin-
containing agar plates. After two single mutations had been engineered (i.e., Asn131Cys and 
Asn171Cys), the pET-28α-EFSAM-Asn131Cys was used as template to generate a cDNA 
containing the double mutation (i.e., Asn131Cys/Asn171Cys).  
For mammalian cell protein expression, the previously described pCMV6 vector 
encoding full-length human STIM1 (i.e., residues 1-685) with mCh fused just after the ER 
signal peptide (i.e., residue 1-23) was used (Stathopulos et al., 2008). The Asn131 and 
Asn171 residues were mutated to glutamine in the pCMV6-mChSTIM1 vector using the 
same mutagenesis approach as described above and the mutagenic primers described in 
(Table 2.1). Colonies harboring the mutated pCMV6-mChSTIM1 plasmid were selected on 
ampicillin-containing agar plates. The double Asn131Gln/Asn171Gln mutation was also 
engineered using the pCMV6-mChSTIM1-Asn131Gln vector as a template. 
Table 2.1. Primers used for mutagenesis and sequencing. All primers were synthesized 
by Sigma-Aldrich (St. Louis, MO). 
Primer Nucleotide Sequence 
EFSAM 
Asn131Cys a 
5’-GTCATCAGAAGTATACTGTTGGACCGTGGATGAGG-3’  
3’-CAGTAGTCTTCATATGACAACCTGGCACCTACTCC-5’  
EFSAM 
Asn171Cys a 
5’-CCAAGGCTGGCTGTCACCTGCACCACCATGACAGGG-3’  
3’-GGTTCCGACCGACAGTGGACGTGGTGGTACTGTCCC-5’  
STIM1 
Asn131Gln b 
5’-GTCATCAGAAGTATACCAGTGGACCGTGGATGAGG-3’  
3’-CAGTAGTCTTCATATGGTCACCTGGCACCTACTCC-5’  
STIM1 
Asn171Gln b 
5’-CCAAGGCTGGCTGTCACCCAAACCACCATGACAGGG-3’  
3’-GGTTCCGACCGACAGTGGGTTTGGTGGTACTGTCCC-5’  
T7 terminator c 5'-GCTAGTTATTGCTCAGCGG-3'  
STIM1 c 5’-AGCTCGGGGGCCAACTCTGAGGAG-3’  
 aMutagenesis primer for pET-28α 
 bMutagenesis primer for pCMV6-XL5-mCh-STIM1 
 cSequencing primers 
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Table 2.2. PCR amplification template on LifeECO (Bioer)   
pET-28α 
parameters 
pCMV6 
parameters 
10-Cycles 25-Cycles 25-Cycles 
Temp 
(°C) Time 
Temp 
(°C)  Time 
Temp 
(°C) Time 
Initial Denaturation 98.0 35 s 98.0 35 s 98.0 30 s 
#-Cycles  
Denaturation 98.0 10 s 98.0 10 s 98.0 10 s 
Annealing 56.5 30 s 56.5 30 s 55.5 30 s 
Extension 72.0 5 min 72.0 5 min 72.0 3 min 
Final Elongation 72.0 5 min 30 s 72.0 5 min 
Storage 4.0 Hold 4.0 Hold 4.0 Hold 
26 
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All mutant pET-28α-EFSAM constructs (i.e., Asn131Cys, Asn171Cys, 
Asn131Cys/Asn171Cys) were verified by dideoxy sequencing using the T7 reverse 
terminator primer (Table 2.1) at the Robart’s DNA Sequencing facility 
(http://www.robarts.ca/london-regional-genomics-centre). Successful mutagenesis of the 
pCMV6-mChSTIM1 constructs (i.e., Asn131Gln, Asn171Gln, Asn131Gln/Asn171Gln) was 
verified using an in-house designed primer (Table 2.1) and sequenced at the Robart’s DNA 
Sequencing facility. 
 
2.2 Protein expression and purification 
2.2.1 Protein expression  
pET-28α-EFSAM (i.e., wild-type, Asn131Cys, Asn171Cys, Asn131Cys/Asn171Cys) 
were separately transformed into E. coli BL21 ΔE3 codon (+) competent cells and plated on 
kanamycin resistant Luria broth (LB) agar plates. A single colony was picked and 
subsequently cultured in 1 L of LB medium supplemented with 60 µg/ml kanamycin at 37 °C 
and ~190 rpm, until the optical density at 600 nm (OD600) reached 0.6-0.8. Subsequently, 200 
µM of isopropyl β-D-1-thiogalactopyranoside (IPTG) was added to induce protein 
expression. After IPTG addition, the cells were incubated at ambient temperature overnight 
with constant shaking. Bacteria were harvested by centrifugation in a J2-21M Induction drive 
centrifuge (Beckman, Inc.) with JA10 rotor at 7250 rpm, 4 °C for 25 min, and the cell pellet 
was collected and stored at -80 °C until purification.  
For uniformly 15N-labelled EFSAM proteins used in the solution NMR experiments 
(see below), bacterial cells were grown in M9 minimal media salts (i.e., 42.2 mM of 
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Na2HPO4 anhydrous, 22.0 mM of KH2PO4, 8.6 mM of NaCl, pH7.4 in 1 L) supplemented 
with a 0.2 µm filtered mixture of 0.2% w/v D-glucose, 100 µM CaCl2, 50 µM thiamine,  
1 mM MgSO4, 1 mg/L biotin, 1 g/L 15N-NH4Cl labeling, and 60 µg/ml kanamycin. Cell 
growth, IPTG induction, cell harvesting and purification (see below) were exactly as 
described for LB broth (see above).  
2.2.2 Protein purification  
Since EFSAM formed inclusions due to the low intracellular Ca2+ levels of E. coli, 
the frozen bacterial cell pellet was manually homogenized in 6 M guanidine-HCl and 20 mM 
Tris-HCl (pH 8), to resolubilize the aggrepated protein. Approximately 30 mL of guanidine-
HCl was added per 5 mL of wet cell pellet. Subsequently, the mixture was incubated for 90 
min at ambient temperature with constant rotation in a hybridization oven. The homogenized 
mixture was subsequently centrifuged in J2-21M Induction drive centrifuge (Beckman, Inc.) 
with JA10 rotor at 7500 rpm, 8 °C for 40 min to separate the insoluble cell debris (pellet) 
from the soluble protein mixture (i.e., supernatant). 750 µL of a 50% (v/v) Ni-Nitrilotriacetic 
acid agarose bead slurry (Qiagen, Inc.) was added to the clarified lysate (~30 mL) and 
incubated for another 90 min at room temperature by inversion in a hybridization oven. 
Subsequently, the beads with captured 6×His-tagged proteins were collected in a gravity flow 
protein purification column and washed 3 times with 10 mL of 6 M urea with 20 mM Tris-
HCl pH 8 and 5 mM β-mercaptoethanol for the mutant proteins. The proteins were eluted in 
7 2-ml fractions using 6 M urea, 20 mM Tris-HCl pH 8, 300 mM imidazole, and 5 mM β-
mercaptoethanol for the mutant proteins (Figure 2.1A). The eluted protein fractions were 
pooled into a dialysis membrane with a 3500 Da molecular weight cutoff (BioDesign Inc.) 
and incubated in 1 L refolding buffer (Table 2.3) at 4°C overnight.  
Figure 2.1. SDS-PAGE gel analyses of STIM1 EFSAM purification. (A) Wild-type 
6×His-EFSAM (~19 kDa) protein elution fractions from Ni-NTA beads. (B) Migration of 
wild-type EFSAM before (~19 kDa) and after (~17 kDa) 6×His thrombin digestion. The 
gels in (A) and (B) were 15 % (v/v) stained with Coomassie blue, and the molecular 
weight marker migration is shown at the leftmost lane of each gel. 
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Table 2.3. Components of the experimental buffers used in the thesis research.  
Refolding buffer 
20 mM Tris-HCl pH 8.0, 150 mM NaCl,  
5 mM CaCl2, 1 mM dithiothreitol (DTT) for 
mutants  
Ion Exchange Buffer A 20 mM Tris-HCl pH 8, 5 mM CaCl2,  1 mM DTT for the mutants  
Ion Exchange Buffer B 20 mM Tris-HCl pH 8, 1 M NaCl, 5 mM CaCl2,  1 mM DTT for the mutants  
Ca2+-loaded buffer 
20 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM 
CaCl2, 1 mM tris(2-carboxyethyl)phosphine 
(TCEP) for non modified mutants  
Ca2+-free buffer 20 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM TCEP for non-modified mutants  
Modification Buffer 
20 mM 3-(N-morpholino)propanesulfonic acid 
(MOPS) pH 8.3, 150 mM NaCl, 5 mM CaCl2, 
0.1 mM TCEP  
Modified Ca2+-loaded buffer 20 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM CaCl2  
Modified Ca2+-free buffer 20 mM Tris-HCl pH 7.5, 150 mM NaCl  
30 
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After overnight refolding, approximately 1 U of thrombin (BioPharm Laboratories, Inc.) per 
mg of protein was added directly to the dialysis bag and incubated again at 4 °C overnight. 
Successful cleavage of 6×His tag was verified by a shift in the migration of the protein 
visualized by Coomassie-blue staining of denaturing polyacrylamide gels, after 
electrophoresis (Figure 2.1B). 100 µM of 4-(2-Aminoethyl) benzenesulfonyl fluoride 
hydrochloride (AEBSF) was added before further purification to inhibit thrombin and other 
proteases until further purification.  
2.2.3 Anion Exchange chromatography  
Anion exchange chromatography was used to further purify the EFSAM proteins, 
with an increasing NaCl gradient (Buffer B). Protein solutions were concentrated 
approximately 10-fold then re-diluted in a NaCl-free (Buffer A) (Table 2.3). Protein was 
manually loaded onto a HiTrapTM Q FF anion exchange column (GE Healthcare, Inc.) using 
a 10 mL syringe. Proteins were eluted in a gradient [i.e., 0 – 60 % (v/v)] of increasing Buffer 
B (Table 2.3) (Figure 2.2A). Ion exchange elution fractions were assessed for purity using 
Coomassie blue-stained SDS-PAGE gels (Figure 2.2B). Fractions with purity of > 95 % were 
pooled and exchanged to Ca2+-loaded buffer (Table 2.3) using a Vivaspin20 centrifugal 
concentrator (Sartorius, Inc.). 
2.2.4 Preparation of Ca2+-free apo protein samples 
To prepare Ca2+-free (i.e., apo) protein samples, 25 mM of ethylenediamine 
tetraacetic acid (EDTA) was added to the sample and incubated overnight at 4 °C. Samples 
were concentrated to ≤1 mL and diluted in the buffer of interest, Ca2+-free buffer (Table 2.3), 
to ~20 ml and re-concentrated to 1 mL using Vivaspin20 exchanger (Sartorius, Inc.). This 
process was repeated three times for a 20×20×20-fold exchange.  
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Figure 2.2. Anion exchange chromatographic separation of wild-type EFSAM 
protein. (A) Anion exchange chromatogram of wild-type EFSAM in an increasing NaCl 
gradient [i.e., 0 to 60 % (v/v)]. The blue line represents the UV absorbance at 280 nm 
and the red line represents the % (v/v) gradient of 1 M NaCl. (B) Coomassie blue stained 
SDS-PAGE gel [15 % (v/v)] of the wild-type EFSAM elution fractions shown in (A). 
The leftmost lane shows the molecular weight marker migration. 
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2.3 Neo-glycosylation of EFSAM  
The protein sample was exchanged into the modification buffer (Table 2.3) using the 
same exchange approach mentioned above (2.2.4). A 55 mM stock solution of N-(β-D-
glucopyranosyl)-N’-[2-methanethiosulfonyl)ethyl]urea (MTS-5-glucose) (Toronto Research 
Chemicals, Inc.) was prepared in dimethylsulfoxide (DMSO). A final concentration of 2 mM 
MTS-5-glucose was added to ~60 µM protein samples and incubated in the dark for 1 h at 
ambient temperature with mixing by gentle tapping of the microfuge tube every 10 min. 
Subsequently, the protein was re-exchanged into the final modified Ca2+-loaded buffer using 
a Vivaspin20 centrifugal concentrator (Sartorius, Inc.). Modified apo protein samples were 
prepared exactly as described for the Ca2+ loaded samples, using however, the modified Ca2+-
free buffer shown in Table 2.3. The glucose conjugation to the protein is termed neo-
glycosylation in this thesis; therefore, modified EFSAM proteins are referred to as neo-
glycosylated EFSAMs.  
To validate the modification protocol, I performed electrospray ionization mass 
spectrometry on the Asn171Cys EFSAM protein sample which I was able to obtain at the 
highest yield, compared to all the mutant EFSAMs studied. The unmodified Asn171Cys 
mutant has a theoretical mass of 17,346.38 Da, and the MTS-5-glucose compound has a mass 
of 360.40 Da. Upon successful modification, the expected mass of gl-Asn171Cys protein 
(MTS-5-glucose modification represented as gl) is 17,626.67 Da [i.e., 17,346.38 – H+ (1.01) 
+ 360.40 – CH3SO2 (79.10)]. The modified gl-Asn171Cys sample was exchanged into 20 
mM ammonium bicarbonate and 2 mM CaCl2, pH 8 using the dialysis method. The prepared 
sample was sent to the Biological Mass Spectrometry Laboratory in London Regional 
Proteomic Centre (http://www.uwo.ca//biochem/lrpc/LRPC.html). The mass spectrum 
revealed the bulk of the protein had a mass of 17,628.05 Da, which was within 1.4 Da of the 
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expected theoretical mass for the glucose modified Asn171Cys protein (i.e., gl-Asn171Cys) 
(Figure 2.3). Importantly, no detectable unmodified Asn171Cys protein was observed in the 
spectrum above the baseline level, confirming a highly efficient modification procedure. The 
relatively large intensity peak observed at 17,380.78 Da corresponds to +34 Da or -247 Da 
compared to the unmodified and modified protein, respectively, and so the identity of this 
peak could not be reliably inferred. After validation of the modification protocol by this mass 
spectrometry experiment, a similar procedure was used to modify the Asn131Cys and 
Asn131Cys/Asn171Cys proteins; additional confirmation of the modification was obtained 
by solution NMR, which gave no indication of peak doubling associated with partial 
modification. 
 
 
 
 
 
 
 
 
Figure 2.3. Positive ionization electrospray mass spectrum of glucose conjugated 
Asn171Cys EFSAM protein. Approximately 57 nM of protein was exchanged in 20 
mM ammonium bicarbonate and 2 mM CaCl2, pH 8. The mass spectrometry measured 
mass of gl-Asn171Cys was within 1.4 Da of the expected theoretical mass; Asn171Cys 
+ gl = 17,346.38 + 280.40 = 17,626.78. 
17380.78 
17312.38 
17628.05 
R
el
at
iv
e 
In
te
ns
ity
 (%
) 
gl-Asn171Cys 
Asn171Cys 
100 
17200            17300           17400           17400           17600            17700            17800           17900           18000 
0 
Mass 
35 
36 
 
2.4 Far-UV circular dichorism (CD) spectroscopy  
A Jasco-J-810 Spectrometer equipped with a Jasco PTC-423S temperature controller 
was used to measure the far-UV CD spectra for samples prepared at 1 mg/mL in the presence 
and the absence of 5 mM CaCl2. A 0.01 cm pathlength quartz cuvette was used to acquire the 
CD spectra. Spectra were collected at 4 °C between 250 nm to 190 nm, with a scanning 
speed of 20 nm/min, response time 8 s, an average of 3 accumulations and 1 nm data pitch. 
Protein spectra were corrected for buffer contributions. 
2.4.1 Thermal stability using far-UV CD spectroscopy 
Thermal stabilities were taken from the change in ellipticity at 225 nm as a function 
of temperature. For these thermal melts, a 0.1 cm pathlength quartz cuvette was used with 
protein concentrations of ~0.5 mg/mL. The temperature was increased from 4 °C to 75 °C at 
1 °C/min and data were collected with an 8-s response time, and 1°C data pitch. From the 
spectrum, the apparent midpoint of temperature denaturation (Tm) was determined using the 
Boltzmann sigmoid equation: 𝑌 = 𝑀𝑖𝑛 + (𝑀𝑎𝑥 −𝑀𝑖𝑛) (1+ 10 !"#$%!𝒳 ∙!"#$% )  
where Y is the change in CD signal, Min represents the bottom plateau, Max represents the 
top plateau, and 𝒳 is the temperature. 
2.4.2 Ca2+ binding affinity using far-UV CD spectroscopy 
Ca2+ binding curves were constructed from the change in ellipticity at 225 nm as a 
function of changing CaCl2 concentrations. For these binding curves, a 0.1 cm pathlength 
quartz cuvette was used with apo protein samples at 0.5 mg/mL. The far-UV CD spectra 
were acquired at 4 °C from 250 nm to 200 nm, with a scanning speed of 20 nm/min, response 
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time of 8 s, an average of 3 accumulations and 1 nm data pitch. A spectrum was acquired 
after the addition of fourteen CaCl2 titration points between 0 and ~16 mM CaCl2. The 
spectral intensities were corrected for the dilution associated with the volume change caused 
by the addition of each aliquot of CaCl2. Ca2+ binding curves were fit and the fitted apparent 
equilibrium dissociation constant (Kd) was determined using a one site-binding model that 
takes into account protein concentration:  𝑃 + 𝐶𝑎 !" 𝑃𝐶𝑎, 𝑃𝐶𝑎 = ½[𝐾𝑑 + 𝑃𝑡𝑜𝑡 + 𝐶𝑎 − 𝐾𝑑 + 𝑃𝑡𝑜𝑡 + 𝐶𝑎 ! − 4𝑃𝑡𝑜𝑡 ∙ 𝐶𝑎]  
where P is the free protein, Ca is the free Ca2+, PCa is the bound protein, and Ptot is the total 
protein concentration. 
 
2.5 Solution NMR spectroscopy 
Approximately 100-200 µM of protein solubilized in 20 mM Tris, 150 mM NaCl, pH 
7.5 was supplemented with 60 µM of 4,4-dimethyl-4-silapentane-1-sulfonic acid (DSS) and 
10 % D2O (v/v) in a final volume of 600 µL. The samples were loaded into a 5 mm NMR 
tube. 1H-15N HSQC spectra (Kay et al., 1992; Farrow et al., 1994) were obtained at 25 °C on 
a Varian Inova 600 MHz NMR spectrometer equipped with a triple resonance HCN 
cryogenic probe. The number of transients was set to 256, and the number of increments in 
the nitrogen dimension was set to 64 for all the samples. The 1H and 15N sweep widths were 
8,000 and 1,800 Hz, respectively. All NMR spectra shown were chosen based on the highest 
signal to noise given for each sample group: Wild-type (n=2), Asn131Cys and gl-Asn131Cys 
(n=3), Asn171Cys and gl-Asn171Cys (n=4), Asn131Cys/Asn171Cys and gl-Asn131Cys/gl-
Asn171Cys (n=2). The neo-glycosylated spectra were compared to the unmodified spectra by 
supplementing the samples with 15 mM DTT to fully remove the glucose moiety by 
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reduction. Total chemical shift perturbations (CSP) were calculated from the chemical shift 
differences observed in the 15N and 1H dimensions of each peak and normalizing for the 
larger 15N chemical shift range using the following equation:  𝐶𝑆𝑃 = [∆𝐻! + 0.14 ∙ ∆𝑁! ]  
where ΔH is the ppm change in proton dimension, and ΔN is the ppm change in the nitrogen 
dimension.  
 
2.6 Static Light Scattering (SLS) 
Stock protein samples were centrifuged at 8,500 g for 5 min at 4 °C to remove any 
pre-exiting aggregates and precipitates. After measuring protein concentration using 
absorbance at wavelength 280nm and an extinction coefficient of 1.6062, samples were 
diluted to a concentration 0.2 mg/mL in the appropriate Ca2+-loaded buffers (Table 2.3). 100 
µL of 0.2 mg/mL protein samples were subsequently centrifuged in a Legend Micro 21R 
Centrifuge (Thermo Scientific, Inc.) at 15,000 g for 5 min at 4 °C. 25 µL of the supernatant 
was aliquoted into a clean quartz MicroCuvette and the SLS intensity at 90 ° was measured 
on a DynaPro Nanostar (Wyatt Technology) at 658 nm with the laser power attenuated to 10 
%, for 6 consecutive measurements (10 s each) at 37 °C.  
To assess the Ca2+-depletion-dependent oligomerization propensity, 50 mM EDTA 
was added to the sample in the cuvette and mixed by pipetting. SLS intensity after the EDTA 
addition was measured with the laser power attenuated to 10 % for 360 consecutive 
measurements (i.e., 10 s each) at 37 °C. The 10 consecutive measurements that showed the 
highest intensity were taken for statistical analysis. To assess the Ca2+-independent 
oligomerization propensity, 100 µL of 0.2 mg/mL protein samples were centrifuged in a 
Legend Micro 21R Centrifuge (Thermo Scientific, Inc.) at 15,000 x g for 5 min at 4°C. 
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Subsequently, 80 µL of the supernatant was removed. The pellet was re-suspended in the 
remaining 20 µL protein solution and 5 µL was used for the SLS measurements with the laser 
power attenuated to 10 % at 37°C for 9 consecutive measurements (10 s each).  
 
2.7 Live cell experiments 
2.7.1 Cell culture  
HEK293 cells stably expressing YFP-Orai1 were generously gifted by Dr. Monica 
Vig from Washington University in St. Louis (St. Louis, MO) (Miao et al., 2013). Cells were 
maintained at 37 °C in a 5% CO2/95% air humidified incubator in Dulbecco’s modified eagle 
medium (DMEM) supplemented with 10 % (v/v) fetal bovine serum (Wisent, Inc.), 100 
µg/ml penicillin-streptomycin, and 0.4 mg/ml G418 Disulfate (Fisher Scientific, Inc.). 
HEK293-YFP-Orai1 cells were passaged at ~80% confluency using the following procedure. 
First the cell culture medium was aspirated off the dish; subsequently, the adherent cells were 
gently washed with 10 mL of warm phosphate buffered saline (PBS). After PBS removal by 
aspiration, 1 mL trypsin/EDTA (Wisent, Inc.) was added per 10- cm plate, and the plate was 
incubated for ~3 min at 37°C. 9 mL of warm culture medium with serum was used to inhibit 
the trypsin and ~20-30% of the cell mixture was re-plated with fresh medium to 10 mL onto 
a new plate.  
2.7.2 Transfection 
The cells were transfected at ~70-80% confluency in a 10-cm dish with PolyJetTM In 
Vitro DNA transfection reagent (SignaGen Laboratories, Inc.) according to the 
manufacturer’s instructions. 24 h before the experiment, the medium was replaced with 10 
mL of fresh medium and the cells were cultured for 60 min at 37°C. 4 µg of DNA was mixed 
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with 10 µL of the Polyjet reagent in 500 µL of DMEM high serum free and incubated at 
room temperature for 15 min. The DNA/PolyJet mixture was then added to the cells 
dropwise, and the cultures were incubated at 37 °C for an additional 24 h.  
Transfection efficiency was calculated as the percentage of cells showing mCherry 
Fluorescence, visualized on a Leica DMIRBE fluorescence microscope (Leica Microsytems, 
Inc.) equipped with an Orca-ER digital camera (Hamamatsu Photonics, Inc.) and Volocity 
4.3.2 software. 
2.7.3 Fura2- ratiometric Ca2+ imaging  
After confirming an ~80% transfection efficiency level, the cell medium was 
aspirated and adherent cells were washed once with 5 mL per 10 cm dish of HBSS buffer 
(140 mM NaCl, 4.7 mM KCl, 1.13 mM MgCl, 10 mM glucose, 10 mM 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid (HEPES), pH 7.4) supplemented with 1.8 mM CaCl2. The 
cells were subsequently collected after lifting by gentle pipetting with 3 mL of HBSS buffer 
supplemented with 1.8 mM CaCl2, and 3 µM of fura2-AM (Alfa Aesar, Inc.), was added to 
the 3 mL of suspended cells and incubated for 45 min in the dark at 37 °C. Subsequently, the 
cells were diluted to 15 mL with HBSS buffer supplemented with 1.8 mM CaCl2 and 
incubated for another 15 min in the dark at 37 °C. Next, the cells were washed 2× with HBSS 
buffer supplemented with 1.8 mM CaCl2 by centrifuging at 1,000 x g for 6 min at room 
temperature then aspirating the supernatant. The cells were finally washed with HBSS buffer 
nominally free of CaCl2 and re-suspended in 1.2 ml of HBSS buffer. The final number of 
cells in 1.2 mL of HBSS was ~5×106. 
Fluorescence at 340 and 380 nm excitation and 510 nm emission was measured using 
a Cary Eclipse spectrofluorimeter (Varian/Agilent, Inc.) equilibrated at 20°C, with a 
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photomultiplier tube voltage of 700 V and slit widths at 5 and 10 nm. At 60 s, 0.5 µM of TG 
and 0.1 mM EGTA were added. At 600 s, 0.5 mM of CaCl2 and at 900 s, an additional 3.5 
mM of CaCl2 was added. The total experimental running time was 1500 s. Data were plotted 
as a normalized F/F0 ratio to show relative changes in cytosolic Ca2+ levels, where F = 
emission intensity ratio calculated using 340 nm/380 nm excitation wavelengths and F0 = 
average F prior to the addition of TG, as has been done previously (Glitsch et al., 2002; 
Jaiswal et al., 2009; Estrada et al., 2012; Tamouza et al., 2012; Chai et al., 2013; Fuchs et 
al., 2013; Muller et al., 2015). Maximal changes in the fluorescence ratio after TG addition 
was taken as the difference between the average of 11 consecutive intensity responses (i.e. 5 
before and 5 after the highest intensity) and the average baseline F before TG addition. 
Maximal changes after 0.5 mM CaCl2 addition and 3.5 mM CaCl2 were similarly calculated 
compared to the baseline F intensity.  
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3.1 Double neo-glycosylated EFSAM constitutively loses α-
helicity.  
 
In the presence of Ca2+, EFSAM proteins show strong α-helical secondary structure 
defined by negative ellipticity at ~208 and ~225 nm wavelengths in the far-UV circular 
dichroism (CD) spectra (Figure 3.1A). Wild type EFSAM as well as the three mutants (i.e., 
Asn131Cys, Asn171Cys, Asn131Cys/Asn171Cys) show similar α-helicity based on far-UV 
CD spectral shapes. Similarly, single modification of Asn131Cys or Asn171Cys minimally 
perturbs the level of α-helicity in the presence of Ca2+. Remarkably, doubly modified gl-
Asn131Cys/gl-Asn171Cys EFSAM displays less pronounced negative ellipticity at the 208 
and 225 nm wavelengths, suggesting a loss of α-helical secondary structure.  
To estimate the fraction α-helicity of each of the EFSAM variants, we used the online 
web based tool DICHROWEB (Whitmore & Wallace, 2004). The CONTIN algorithm was 
used to deconvolute α-helicity levels. The wild-type protein showed ~40% α-helicity, and all 
the mutations and the single modified mutants showed comparable α-helicity levels (Figure 
3.1C). However, the double glucose modified protein (i.e., gl-Asn131Cys/gl-Asn171Cys) 
showed a significant reduction in α-helicity levels compared to wild-type EFSAM.  
In the absence of Ca2+, modified and unmodified wild-type and mutant EFSAM 
proteins showed a marked loss in the α-helical secondary structure (Figure 3.1B and 3.1C). A 
qualitative assessment of the spectra shows less negative ellipticity at 208 nm and a major 
loss of the ellipticity at 225 nm. A deconvolution of the percentage secondary structure using 
the CONTIN algorithm in DICHROWEB revealed that all the modified and unmodified 
EFSAM proteins show ~17 % α-helicity in the absence of Ca2+, significantly less than the 
respective Ca2+-loaded states (Figure 3.1C). Overall, double glucose modification of EFSAM 
results in a persistent partial loss of the α-helical secondary structure with or without Ca2+.  
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Figure 3.1. Far-UV CD spectra of wild-type, Asn131Cys, Asn171Cys, Asn131Cys/
Asn171Cys, gl-Asn131Cys, gl-Asn171Cys, and gl-Asn131Cys/gl-Asn171Cys EF-SAM 
proteins. (A) Ca2+ loaded EFSAM far-UV CD spectra. Spectra were acquired in 5 mM 
CaCl2, 20 mM Tris, 150 mM NaCl, pH 7.5, at 4°C. Unmodified and modified Ca2+ loaded 
proteins were assessed in the presence and absence of 1 mM TCEP, respectively. (B) Ca2+ 
depleted EFSAM far-UV CD spectra. Spectra were acquired in 0.5 mM EDTA, 20 mM Tris, 
150 mM NaCl, pH 7.5, at 4°C. Unmodified and modified Ca2+ depleted proteins were 
assessed in the presence and absence of 1 mM TCEP, respectively. All the data in (A) and (B) 
are the means ± SEM of n=3-4 separate protein preparations. (C) Percent α-helicity of the 
proteins in the presence and absence of Ca2+. The percentages a-helicity were deconvoluted 
from the spectra shown in (A) and (B) using DICHROWEB. The statistical evaluation was 
two-way analysis of variance (ANOVA) with Bonferroni multiple comparisons test for data 
in the presence of 5 mM CaCl2 and 0 mM CaCl2; *p<0.005, **p<0.0001.  
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3.2 Neo-glycosylated EFSAM proteins are destabilized.  
Tm was taken as a measure of protein stability and determined from the change in far-
UV CD signal at 225 nm as a function of temperature. In the presence of Ca2+, the Tm for the 
wild-type EFSAM protein was ~ 48.5°C. All single and double mutants showed a significant 
thermal destabilization compared to the wild-type control with Tm values ranging from 
~42°C to 44°C (Figure 3.2A). Glucose conjugation of the single mutants marginally 
destabilized EFSAM further by ~0.3-2.0°C; on the other hand, double glucose modification 
at both the Asn131 and Asn171 sites (i.e., gl-Asn131Cys/gl-Asn171Cys) destabilized the 
protein by a more marked ~3.7°C (Table 3.1). Thus, EFSAM stability is sensitive to 
modifications at the Asn131 and Asn171 positions and glucose attachment close to the 
surface of the protein enhances the destabilization.  
In the absence of Ca2+, all protein samples were highly destabilized (Figure 3.2B). 
Such a loss in stability is coupled to the pronounced decrease in α-helicity shown in Figure 
3.1B. Since the Ca2+-depleted EFSAM proteins are in a persistently partially unfolded state, 
only a small additional change in ellipticity occurred during thermal unfolding resulting in 
considerable scatter in the data compared to the Ca2+-loaded proteins. Thus, we were unable 
to reliably determine the Tm values in the absence of Ca2+. Nevertheless, it is clear that 
glucose modified and unmodified Ca2+-depleted EFSAM proteins have a strikingly reduced 
thermal stability compared to their Ca2+-loaded counterparts (Fig. 3.1A and 3.1B). 
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Figure 3.2. Thermal stability of wild-type, Asn131Cys, Asn171Cys, Asn131Cys/
Asn171Cys, gl-Asn131Cys, gl-Asn171Cys, and gl-Asn131Cys/gl-Asn171Cys and 
EFSAM proteins. (A) Thermal melts were acquired in 5 mM CaCl2, 20 mM Tris, 150 
mM NaCl, pH 7.5. Stability was estimated from the change in far-UV CD signal at 225 
nm as function temperature. Unmodified and modified Ca2+ loaded proteins were 
assessed in the presence and absence of 1 mM TCEP, respectively. (B) Thermal melts 
were acquired in 0.5 mM EDTA, 20 mM Tris, 150 mM NaCl, pH 7.5. Unmodified and 
modified Ca2+ depleted proteins were assessed in the presence and absence of 1 mM 
TCEP, respectively. Data in (B) was partially smoothed using three point averaging. All 
data in (A) and (B) are the means ± SEM of n=3-4 separate protein preparations.  
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Table 3.1. Summary of thermal stability changes for mutated and/or glucose modified 
EFSAM proteins.  
Proteins with Ca2+ Tm(°C) a ΔTm mut (°C) b ΔTm mod (°C) c  
Wild-type 48.5 ± 0.18 
Asn131Cys 44.0 ± 0.16* - 4.5 ± 0.24 
Asn171Cys 43.9 ± 0.09* - 4.6 ± 0.20 
Asn131Cys/Asn171Cys 41.5 ± 0.18* - 7.0 ± 0.25 
gl-Asn131Cys 42.0 ± 0.18* - 6.5 ± 0.25 - 2.0 ± 0.24 
gl-Asn171Cys 43.6 ± 0.09* - 4.9 ± 0.20 - 0.3 ± 0.18 
gl-Asn131Cys/gl-Asn171Cys 37.8 ± 0.14* - 10.7 ± 0.23 - 3.7 ± 0.23 
 aTm using the Boltzmann’s fit. One-way ANOVA with Bonferroni multiple 
comparisons test to the control group ‘wild-type’ was used for statistical analysis; 
*p<0.0001.   
 bThe difference of all the other groups to Tm(Wild-type); Tm mut = Tm(mut/mod)-Tm(Wild-type) 
 cThe difference of Tm(unmodified) to that of Tm(modified); Tm mod = Tm(mod)-Tm(mut) 
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3.3 Neo-glycosylation of EFSAM proteins causes local 
structural perturbations. 
 
I used solution NMR to assess structural perturbations caused by the EFSAM 
modifications. Comparisons of the wild type with mutant and glucose-conjugated mutant 
EFSAM protein 1H-15N-HSQC spectra reveal the changes in the backbone structures due to 
modifications at the Asn131 and Asn171 sites. The wild-type EFSAM spectrum closely 
matched the previously published spectrum for this protein which is ~80 % assigned 
(Stathopulos et al., 2008) (BMRB accession number 15851), allowing the assignments to be 
made by transference. Furthermore, reduced spectra with 15 mM DTT perfectly matched the 
mutant spectra before the glucose modification, indicating that DTT addition to the neo-
glycosylated proteins fully reversed the modification process. I observed three CSP hotspots 
caused by the Asn131Cys mutation (i.e., ~between residues 65-73, 121-142 and residues 
156-170) (Figure 3.4A). Glucose-attachment to the Asn131Cys caused further CSPs largely 
localized to these same areas relative to the primary sequence (Figure 3.4B). However, to 
evaluate the overall structural perturbations caused by all the changes at the Asn131 site (i.e., 
mutation + glucose attachment) I compared the gl-Asn131Cys to the wild-type spectrum 
(Figure 3.3) and calculated the CSPs (Figure 3.4C). I mapped the largest CSPs corresponding 
to those greater than 1 and 2 standard deviation (SD) higher than the mean CSPs of all 
residues on the wild-type EFSAM structure. While the three hotspots appear relatively 
distant in sequence space, the perturbation map on the 3D structure revealed that the largest 
CSPs were primarily localized to one face of the EFSAM domain within ~10 Å of the 
Asn131Cys residue (Figure 3.5).  
 
Figure 3.3. 1H-15N HSQC spectrum of gl-Asn131Cys (magenta crosspeaks) overlaid 
with the wild-type (black crosspeaks) spectrum. The spectra were acquired in 5 mM 
CaCl2, 20 mM Tris, 150 mM NaCl, pH 7.5, 20 °C at 600 MHz. The amides of residues 
undergoing CSPs larger than the mean plus 1×SD due to the Cys mutation and the covalent 
addition of the glucose moiety are labeled. The location of gl-Asn171Cys amide is 
indicated with a red ellipse. 
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Figure 3.4. Normalized CSPs derived from the 1H-15N HSQC spectra. (A) 
Normalized CSPs calculated from the Asn131Cys EFSAM spectrum compared to the 
wild-type EFSAM spectrum. (B) Normalized CSPs calculated from the gl-Asn131Cys 
EFSAM spectrum compared to the Asn131Cys EFSAM spectrum. (C) Normalized CSPs 
calculated from the gl-Asn131Cys EFSAM spectrum compared to the wild-type EFSAM 
spectrum. In (A) – (C), the CSPs are shown relative to the STIM1 EFSAM residue 
number, and the CSP levels of the mean (solid horizontal line) and the mean plus 1× and 
2× the standard deviation (SD, broken horizontal lines) are shown. The relative location 
of the STIM1 EFSAM secondary structure elements are shown at the top of panel (C) 
with rectangles and arrows representing α-helical and β-strand elements, respectively.  
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gl-Asn131Cys 
Figure 3.5. The largest magnitude CSPs of gl-Asn131Cys relative to wild-type EFSAM 
mapped on the 3D structure of wild-type EFSAM. The perturbations are shown as blue-
magenta-white gradient on the backbone view of EFSAM where magenta indicates CSPs 
greater than the mean plus 1×SD, and white indicates CSPs greater than the mean plus 2×SD. 
The yellow sphere represents Ca2+. The structure image was rendered in PyMOL using 
2K60.pdb.  
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The Asn171Cys mutation resulted in two main CSP hotspots compared to wild-type 
(i.e., between residues ~64-73 and ~165-190) (Figure 3.7A). The gl-Asn171Cys spectrum 
showed further residue-specific CSPs in the same two regions, consistent with the attachment 
of the glucose moiety (Figure 3.7B). The gl-Asn171Cys spectral changes compared to wild-
type (Figure 3.6) were used to determine the CSPs caused by all the modifications at the 
Asn171Cys site (Figure 3.7C). Similar to the gl-Asn131Cys protein, the two perturbation 
hotspots caused by the gl-Asn171Cys that were separated by hundreds of residues in 
sequence space localized to one face EFSAM within ~10 Å of the Asn171Cys site (Figure 
3.8). 
The spectrum obtained with the double mutant revealed three CSP hotspots between 
residues ~65-79, ~121-135 and ~156-198 (Figure 3.10A). My glucose modification 
procedure caused further residue-specific CPSs in these three hotspots, consistent with the 
attachment of the glucose moiety to both the Asn131Cys and Asn171Cys sites (Figure 
3.10B). While the Asn131Cys modification also caused three CSP hotspots (Figure 3.4C), 
the double modification perturbed a broader range of residues in the SAM domain region, 
consistent with the modification of the Asn171Cys. I calculated the overall CSPs from the 
comparison of the gl-Asn131Cys/gl-Asn171Cys spectrum to wild-type spectrum (Figure 
3.9). Again, while the three main CSP regions were separated in sequence space (Figure 
3.10C), plotting the most perturbed residues on the 3D EFSAM structure revealed two 
distinct clusters of structural changes (Figure 3.11). The first cluster was around the 
Asn131Cys site and the second cluster surrounded to the Asn171Cys site.  
 
 
Figure 3.6. 1H-15N HSQC spectrum of gl-Asn171Cys (cyan crosspeaks) overlaid 
with the wild-type (black crosspeaks) spectrum. The spectra were acquired in 5 mM 
CaCl2, 20 mM Tris, 150 mM NaCl, pH 7.5, 20 °C at 600 MHz. The amides of residues 
undergoing CSPs larger than the mean plus 1×SD due to the Cys mutation and the 
covalent addition of the glucose moiety are labeled. The location of gl-Asn171Cys 
amide is indicated with a red ellipse.  
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Figure 3.7. Normalized CSPs derived from the 1H-15N HSQC spectra. (A) 
Normalized CSPs calculated from the Asn171Cys EFSAM spectrum compared to the 
wild-type EFSAM spectrum. (B) Normalized CSPs calculated from the gl-Asn171Cys 
EFSAM spectrum compared to the Asn171Cys EFSAM spectrum. (C) Normalized CSPs 
calculated from the gl-Asn171Cys EFSAM spectrum compared to the wild-type EFSAM 
spectrum. In (A) – (C), the CSPs are shown relative to the STIM1 EFSAM residue 
number, and the CSP levels of the mean (solid horizontal line) and the mean plus 1× and 
2× the standard deviation (SD, broken horizontal lines) are shown. The relative location 
of the STIM1 EFSAM secondary structure elements are shown at the top of panel (C) 
with rectangles and arrows representing α-helical and β-strand elements, respectively.  
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gl-Asn171Cys 
Figure 3.8. The largest magnitude CSPs of gl-Asn171Cys relative to wild-type EFSAM 
mapped on the 3D structure of wild-type EFSAM. The perturbations are shown as blue-
green-white gradient on the backbone view of EFSAM where green indicates CSPs greater 
than the mean plus 1×SD, and white indicates CSPs greater than the mean plus 2×SD. The 
yellow sphere represents Ca2+. The structure image was rendered in PyMOL using 
2K60.pdb. 
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Figure 3.9. 1H-15N HSQC spectrum of gl-Asn131Cys/gl-Asn171Cys (orange 
crosspeaks) overlaid with the wild-type (black crosspeaks) spectrum. The spectra 
were acquired in 5 mM CaCl2, 20 mM Tris, 150 mM NaCl, pH 7.5, 20 °C at 600 MHz. 
The amides of residues undergoing CSPs larger than the mean plus 1×SD due to the Cys 
mutations and the covalent addition of the glucose moieties are labeled. The location of 
gl-Asn131Cys and gl-Asn171Cys amides are indicated with red ellipses. 
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Figure 3.10. Normalized CSPs derived from the 1H-15N HSQC spectra. (A) 
Normalized CSPs calculated from the Asn131Cys/Asn171Cys EFSAM spectrum 
compared to the wild-type EFSAM spectrum. (B) Normalized CSPs calculated from the 
gl-Asn131Cys/gl-Asn171Cys EFSAM spectrum compared to the Asn131Cys/
Asn171Cys EFSAM spectrum. (C) Normalized CSPs calculated from the gl-
Asn131Cys/gl-Asn171Cys EFSAM spectrum compared to the wild-type EFSAM 
spectrum. In (A) – (C), the CSPs are shown relative to the STIM1 EFSAM residue 
number, and the CSP levels of the mean (solid horizontal line) and mean plus 1× and 2× 
the standard deviation (SD, broken horizontal lines) are shown. The relative location of 
the STIM1 EFSAM secondary structure elements are shown at the top of panel (C) with 
rectangles and arrows representing α-helical and β-strand elements, respectively.  
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Collectively, the structural analysis by solution NMR revealed successful site-specific 
glucose attachment to both the single and double mutant EFSAM proteins. Additionally, the 
CSPs revealed that the structural perturbations are localized to near the Asn131Cys or 
Asn171Cys sites for the single modifications and appear to be largely additive for the double 
mutant. 
 
3.4 Neo-glycosylation lowers EFSAM Ca2+ binding affinity. 
Kd values of Ca2+ binding were determined from the change in far-UV CD signal at 
225 nm as a function of increasing Ca2+ concentrations (Figure 3.12A and 3.12B). Wild-type 
EFSAM had the lowest Kd value (~0.18 mM) compared to all other EFSAM proteins, 
indicating the highest Ca2+ affinity (Table 3.2). Mutation of Asn131 or Asn171 decreased the 
Ca2+ binding affinity by ~1 order of magnitude. Glucose modification did not appreciably 
alter these weakened affinities. Interestingly, the double mutation with or without the 
modifications showed the weakest affinities compared to wild-type EFSAM. 
A comparison of the structural changes associated with Ca2+ binding shows that wild-
type EFSAM regains considerable α-helicity as a function of increasing Ca2+ concentration 
(Figure 3.12C). On the other hand, the double modified mutant shows a resistance to 
refolding and remains in a persistent reduced α-helical state as a function increasing Ca2+ 
levels (Figure 3.12D). Together, these binding affinity data reveal a remarkable sensitivity of 
EFSAM to any modification associated with the Asn131 or Asn171 sites despite the 
peripheral localization of these residues far from the EF-hand Ca2+ coordinating residues; 
further, double mutation and/or modification of the Asn131 and Asn171 sites further 
potentiates weaker binding and leaves the EFSAM core in a persistently partially unfolded 
state. 
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Figure 3.12. Ca2+ binding curves derived from changes in far-UV CD ellipticity as a 
function of Ca2+ concentration. (A) Unmodified wild-type and mutant EFSAM Ca2+ 
binding curves acquired in 20 mM Tris, 150 mM NaCl, 1 mM TCEP, pH 7.5. (B) Wild-
type and gl-modified mutant EFSAM Ca2+ binding curves acquired in 20 mM Tris, 150 
mM NaCl, pH 7.5. The binding experiments were performed at 4 °C with increasing 
CaCl2 concentrations from 0 mM to 16.2 mM. All binding curves are constructed from 
n=3 separate experiments as mean responses ± SEM. (C) Representative far-UV CD 
spectral changes with increasing Ca2+ concentrations of wild-type EFSAM (from n=3 
titrations). (D) Representative far-UV CD spectral changes with increasing Ca2+ 
concentrations of gl-Asn131Cys/gl-Asn171Cys EFSAM (from n=3 titrations). 
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Table 3.2. Summary of the equilibrium dissociation constants (Kd) extracted from the 
far-UV CD-derived Ca2+ binding curves.  
Kd (mM) a  
Wild-type 0.18 ± 0.01 
Asn131Cys 1.41 ± 0.48 
Asn171Cys 1.95 ± 0.58 
Asn131Cys/Asn171Cys 4.38 ± 2.33 
gl-Asn131Cys 0.66 ± 0.11 
gl-Asn171Cys 1.04 ± 0.18 
gl-Asn131Cys/gl-Asn171Cys 9.94 ± 6.66 
 aKd was extracted using a one site-binding model that takes into account protein 
concentration.  
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3.5 Neo-glycosylation alters Ca2+-dependent oligomerization 
propensity of EFSAM. 
 
The Ca2+ sensitivity of EFSAM protein oligomerization was assessed using static 
light scattering (SLS) measurements. All samples were centrifuged for 15,000 g and 5 min (4 
°C) to remove high scattering protein aggregates prior to the measurements. For each wild-
type, mutant and modified-mutant sample a baseline SLS intensity in the presence of 5 mM 
Ca2+ was determined. Ca2+-sensitive oligomerization was monitored as the increase in SLS 
intensity upon the addition of 10-fold excess EDTA. The time averaged SLS intensity is 
shown prior to and after the addition of the EDTA (Figure 3.13A). As expected, the wild-
type EFSAM protein showed a dramatic increase in SLS intensity upon Ca2+ chelation 
indicative of Ca2+-depletion-induced oligomerization. The single mutant EFSAMs 
maintained the ability to undergo Ca2+-depletion-dependent oligomerization; however, the 
doubly mutated Asn131Cys/Asn171Cys EFSAM did not respond to Ca2+-chelation. 
Similarly, the gl-Asn131Cys and the gl-Asn131Cys/gl-Asn171Cys protein solutions did not 
show increased SLS intensity upon EDTA addition indicative of a Ca2+-insensitivity. 
Conversely, the gl-Asn171Cys protein showed an increased SLS after Ca2+ chelation as 
observed for wild-type EFSAM. 
The Ca2+ insensitivity of Asn131Cys/Asn171Cys, gl-Asn131Cys and gl-
Asn131Cys/gl-Asn131Cys may reflect the instability of these proteins which were the least 
thermally stable in the presence of Ca2+ (Table 3.1). The Asn131Cys, Asn171Cys and the gl-
Asn171Cys all had a similar Tm and all were responsive to Ca2+ chelation (Table 3.1). Thus, I 
hypothesized that I did not observe persistently high SLS intensity for the 
Asn131Cys/Asn171Cys, gl-Asn131Cys and gl-Asn131Cys/gl-Asn131Cys proteins due to the 
centrifugation steps which removes protein aggregates. Therefore, to confirm that the 
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Asn131Cys/Asn171Cys, gl-Asn131Cys and gl-Asn131Cys/gl-Asn131Cys proteins were pre-
aggregated, I re-suspended the pellets formed after centrifugation and measured the SLS 
intensity as an indicator of aggregation state. The samples with low SLS intensity before and 
after EDTA addition all exhibited significantly higher SLS intensity compared to wild-type 
EFSAM prior to EDTA addition, suggesting that significantly more protein aggregates 
formed even in the presence of Ca2+ compared to control (Figure 3.13B). Taken together, 
these light scattering data suggest that modifications of EFSAM at the Asn131 and Asn171 
sites increase the propensity for EFSAM oligomerization. 
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Figure 3.13. Oligomerization propensity of EFSAM proteins assessed by SLS intensity. 
(A) Ca2+-depletion dependent oligomerization assessed after chelation of Ca2+. SLS intensity 
is shown before and after Ca2+ chelation using EDTA for each protein sample. Statistical 
analysis is a two-way ANOVA with Bonferroni multiple comparisons test comparing SLS 
intensity before and after 50 mM EDTA addition within each group; *p<0.0001. (B) Ca2+-
depletion independent oligomerization assessed in the absence of Ca2+ chelation. SLS 
intensity of the resuspended aggregates pelleted by centrifugation is shown for each protein 
sample. Statistical analysis was performed using one-way ANOVA with Dunnett multiple 
comparisons test to the wild-type control group; *p<0.05, **p<0.0001. All data in (A) and 
(B) are of n=3 separate experiments acquired in 5 mM CaCl2 20 mM Tris, 150 mM NaCl, 1 
mM TCEP for unmodified mutants or no TCEP for modified mutants, pH 7.5.  
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3.6 Blocking EFSAM glycosylation within full-length STIM1 
suppresses SOCE. 
 
The ability of the wild-type and mutant STIMs to regulate Ca2+ uptake was tested 
using fura2 ratiometric fluorescence experiments using live HEK293 cells stably expressing 
YFP-Orai1. HEK293-Orai1 cells were transiently transfected with wild-type monomeric 
cherry tagged STIM1 (mChSTIM1) or the corresponding single Asn131Gln or Asn171Gln or 
double Asn131Gln/Asn171Gln glycosylation-incompetent mutants. Passive depletion of the 
ER Ca2+ store using TG caused a transient release of Ca2+ from the lumen that was not 
significantly different between the five groups (i.e., no transfection, mChSTIM1, mChSTIM1 
Asn131Gln, mChSTIM1 Asn171Gln, mChSTIM1 Asn131Gln/Asn171Gln). However, upon 
the addition of 0.5 mM CaCl2 to the external medium, the uptake of Ca2+ for cells transfected 
with doubly mutated STIM1 (i.e., mChSTIM1 Asn131Gln/Asn171Gln) displayed a 
significantly smaller rise in the fluorescence ratio, indicating there was lower Ca2+ uptake 
from the extracellular space compared to that of wild-type mChSTIM1 and single mutant 
expressing cells (Figure 3.14). Surprisingly, after supplementing the external medium with an 
additional 3.5 mM CaCl2 both the mChSTIM1 and mChSTIM1 Asn131Gln/Asn171Gln 
proteins induced similar levels of uptake, whereas the single mutants maintained the trend 
observed at lower external CaCl2 of inducing higher levels of Ca2+ entry compared to the 
double mutant. Taken together, these data show that blocking EFSAM glycosylation within 
full-length STIM1 decreases SOCE-mediated Ca2+ influx at relatively low levels of external 
Ca2+ consistent with a role for glycosylation in enhancing the oligomerization propensity of 
the domain and activation of Orai1 channels, and intriguingly, relatively high levels of 
external Ca2+ may differentially affect the function of glycosylated and nonglycosylated 
STIM proteins. 
(A) 
(B) 
Figure 3.14. Assessment of SOCE mediated by wild-type and glycosylation-
incompetent full length STIM1 proteins in HEK293 live cells. (A) Changes in the 
Fura-2 fluorescence ratio reporting the relative changes in the cytosolic Ca2+ levels 
upon depletion of ER Ca2+ stores by external addition of 0.5 µM TG and 0.1 mM EGTA 
(horizontal green bar). SOCE was monitored after the addition of 0.5 mM and 4.0 mM 
excess CaCl2 to the external medium at the time points indicated by the yellow and 
orange horizontal bars, respectively. (B) Maximal relative changes in the Fura-2 
fluorescence ratio after 0.5 mM TG, 0.5 mM and 4.0 mM external CaCl2 additions. 
Statistical analysis was performed with two-way ANOVA with Bonferroni multiple 
comparisons test to the mChSTIM1 control group. *p<0.01, **p<0.001. Data in (A) and 
(B) are from HEK293 cells stably expressing YFP-Orai1 and transiently co-expressing 
wild-type (n=8), Asn131Gln (n=3), Asn171Gln (n=3) or Asn131Gln/Asn171Gln (n=14) 
mChSTIM1.  
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4 Chapter 4 
Discussion 
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4.1 Summary of key findings 
Although the STIM1 glycosylation sites were identified over 15 years ago (Williams 
et al., 2001, 2002), studies on how STIM1 N-glycosylation affects SOCE have been 
inconsistent and ambiguous (Mignen et al., 2007; Csutora et al., 2008; Czyz et al., 2009; 
Kilch et al., 2013). Therefore, this thesis investigated the effect of such glycosylation on the 
biophysical properties and structure of the Ca2+ sensing EFSAM domain, as well as the 
function of the modified domain within full-length STIM1. I hypothesized that neo-
glycosylation of the EFSAM domain alters the biophysical properties of the domain in a 
manner that is intimately tied to the ability of STIM1 to regulate SOCE. In summary, the 
double glucose-conjugated mutant EFSAM protein (i.e., gl-Asn131Cys/gl-Asn171Cys) 
exhibited a partial loss in α-helical secondary structure even in the presence of Ca2+. 
Consistent with this structural change, the double modified sample had the lowest thermal 
stability compared to all other groups. Moreover, variation of the Asn131 or Asn171 sites 
decreased the Ca2+ binding affinity, as well as revealed 3D structural perturbations localized 
near the modification site(s) when examined by NMR. From oligomerization studies, doubly 
mutated and doubly modified EFSAM samples showed increased oligomerization even in the 
presence of Ca2+, implying an increased ability to initiate and activate SOCE. Consistent with 
this notion, STIM1 functional studies showed a suppressed Ca2+ influx via the SOCE 
pathway when glycosylation was blocked by mutation at the Asn131 and Asn171 sites. Thus, 
my hypothesis was supported by my in vitro and mammalian cell culture results, 
demonstrating that glycosylation of the EFSAM domain endows STIM1 with another layer 
of regulation through modification of the Ca2+ sensing properties of the protein.  
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4.2 Neo-glycosylation alters the fundamental Ca2+ sensing 
properties EFSAM proteins. 
4.2.1 Glycosylation structurally perturbs STIM1 EFSAM 
STIM1 protein is activated when Ca2+ dissociates from its binding site, resulting in a 
partial unfolding coupled with destabilization of the domain; moreover, it has been suggested 
that the EF-hand domain of EFSAM adopts a “closed” conformation similar to CaM in the 
absence of Ca2+ (Stathopulos et al., 2008), but the precise atomic resolution structure of the 
apo state is unknown. Interestingly, I discovered that glucose-conjugated EFSAM proteins 
(i.e. gl-Asn131Cys/gl-Asn171Cys) displayed a significantly lower percentage α-helicity 
compared to wild-type EFSAM proteins, suggesting a constitutive partial loss in α-helicity in 
the presence of Ca2+ (Figure 3.1). This result is supported by my thermal stability studies 
(Figure 3.2) which showed that gl-Asn131Cys/gl-Asn171Cys had the lowest thermal stability 
(Tm ~37.8 °C), a value almost 11°C lower than that of the wild-type Tm (Table 3.1). These 
findings imply that even in the presence of Ca2+, fully glycosylated EFSAM within STIM1 
would be partially unfolded and STIM1 would be activated. However, it is important to note 
that the non-conserved luminal region of STIM1 (i.e. residues 23-57) stabilizes the EFSAM 
core domain by ~15 °C (Stathopulos et al., 2009). Thus, the double glycosylation of EFSAM 
counteracts the stabilization caused by the non-conserved N-terminal residues by 
destabilizing the conserved EFSAM domain, thereby adapting the protein for a role in ER 
Ca2+ sensing associated with SOCE activation.  
It has been previously shown that a balance between EF-hand Ca2+ binding affinity 
and SAM domain stability tunes the two human homologues of STIM1 and STIM2 to 
specific roles as a basal Ca2+ homeostasis regulator (i.e., STIM2) and a robust SOCE 
ON/OFF regulator (i.e., STIM1) (Zheng et al., 2011). STIM1 has a higher Ca2+ binding 
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affinity and a lower SAM domain stability, and so it remains inactive after small reductions 
of ER luminal Ca2+. STIM2 has a lower Ca2+ binding affinity, but a higher SAM domain 
stability, and so it is active even after small levels of ER luminal Ca2+ depletion. However, 
the lower SAM domain stability of STIM1 makes it robustly oligomerize after a larger 
magnitude ER Ca2+ depletion, while the higher SAM domain stability of STIM2 makes it less 
oligomerization prone after ER Ca2+ depletion (Zheng et al., 2011). While the addition of the 
non-conserved luminal residues increases both Ca2+ binding affinity (Stathopulos laboratory, 
unpublished data) and stability (Stathopulos et al., 2009), my data suggest that the double 
glycosylation, which is specific only to STIM1, contributes to this balance of Ca2+ binding 
affinity and stability by shifting STIM1 EFSAM to even lower binding affinity and stability, 
thus making STIM1 a robust ON/OFF regulator of SOCE. 
From the differences observed in the secondary structural characteristics after glucose 
conjugation to the EFSAM domain, I expected the modification would also alter the 3D 
protein structure of this domain. Indeed, solution NMR spectroscopy demonstrated CSPs in 
the 1H-15N HSQC spectra of EFSAM as a result of the modification(s). For the singly 
modified EFSAM samples (i.e. gl-Asn131Cys or gl-Asn171Cys), CSPs, and thus structural 
changes, were localized close to the modification sites in 3D space (i.e., ~10 Å maximum 
distance; Figures 3.5, 3.8). Interestingly, for the double-modified gl-Asn131Cys/gl-
Asn171Cys protein, the CSPs appeared to be largely an additive function of the individual 
modifications (Figure 3.10). This result was somewhat unexpected because my far-UV CD 
analyses showed a significantly reduced α-helicity for the doubly modified protein (Figure 
3.1), suggesting a potential synergistic perturbation. However, it is important to note that the 
double modified EFSAM protein tended to oligomerize (see below) even in the Ca2+ loaded 
state, and the fraction of oligomerized protein would not be observable in the standard HSQC 
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experiments due to size limitations of the standard NMR experiments. It is conceivable that 
the doubly modified protein exists in multiple conformations, with the oligomerized partially 
unfolded state not visible in the NMR spectrum. In addition to the CSPs, the doubly modified 
spectrum exhibited a considerable loss in peak intensity that could be caused by multiple 
conformations and/or increased homotypic protein-protein interactions.  
4.2.2 Glycosylation lowers the Ca2+ affinity of STIM1 EFSAM 
Because STIM1 protein activation is initiated by dissociation of Ca2+ from its binding 
site, I also examined the effect of neo-glycosylation on EFSAM Ca2+ binding affinity. All 
mutated or modified EFSAM proteins exhibited a decreased Ca2+ binding affinity compared 
to the wild-type unmodified EFSAM (Table 3.2). However, the apparent Kd was highest (i.e. 
weakest affinity) for the samples that were doubly mutated or doubly modified. Considering 
Ca2+ levels in the ER lumen vary from ~100 to 800 µM, the Kd values estimated for the 
double mutated or double modified EFSAM proteins appear too high to respond to the range 
of changes in ER luminal Ca2+ levels. However, as mentioned above, the STIM1 non-
conserved N-terminal region greatly stabilizes the core EFSAM domain (Stathopulos et al., 
2009), and thus, I believe that the weakened Ca2+ binding affinity caused by glycosylation 
may compensate for the stabilization and increased affinity endowed by the variable N-
terminal region. 
4.2.3 Glycosylation enhances oligomerization of STIM1 EFSAM 
Activated STIM1 forms oligomers which then translocate to ER-PM junctions where 
puncta form (Liou et al., 2005, 2007; Zhang et al., 2005). This process initiates Ca2+ influx 
through the SOCE pathway after coupling and activating Orai1 channels. It has been shown 
that artificial oligomerization of the luminal domain of STIM1 is sufficient to induce 
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translocation and activation of Orai1 channels (Luik et al., 2008). Therefore, oligomerization 
of EFSAM is a fundamental initiation mechanism for STIM1 and SOCE activation. My data 
showed that neo-glycosylation results in EFSAM partial unfolding, decreased stability and 
lower Ca2+ binding affinity that could play a role in increased protein activation. Thus, 
EFSAM oligomerization was studied in response to glucose modification. As predicted, gl-
Asn131Cys/gl-Asn171Cys protein demonstrated persistent oligomerization even in the 
presence of Ca2+ (Figure 3.13). Interestingly, the double mutant EFSAM (i.e. 
Asn131Cy/Asn171Cys) as well as gl-Asn131Cys EFSAM also exhibited oligomers in the 
presence of Ca2+. At the same time, the thermal stability data indicated that 
Asn131Cys/Asn171Cys, gl-Asn131Cys, and gl-Asn131Cys/gl-Asn171Cys proteins had the 
lowest Tm values of 41.5 °C, 42.0 °C, and 37.8 °C respectively, reinforcing the intimate link 
between oligomerization propensity and stability.  
 
4.3 SOCE is suppressed after blocking of STIM1 glycosylation 
in mammalian cells.  
 
While my biophysical studies indicated double glucose modification lowers Ca2+ 
binding affinity, destabilizes, partially unfolds and increases protein oligomerization of 
EFSAM, the link between glycosylation of EFSAM and full-length STIM1 function in the 
cell was unclear based on contradictory findings from multiple groups (see Chapter 1.6.1). 
Therefore, I conducted fura2 cytosolic Ca2+ imaging to examine the effect of glycosylation 
on STIM1 function and SOCE. Remarkably, I discovered that at relatively low levels of 
extracellular CaCl2 (i.e. ~0.5 mM) cells expressing the mChSTIM1 Asn131Gln/Asn171Gln 
double mutant which blocks glycosylation at those mutated sites displayed significantly less 
Ca2+ influx compared to wild-type (Figure 3.14). This data at relatively low extracellular 
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CaCl2 is fully consistent with my biophysical studies where glucose-modification enhances 
EFSAM oligomerization via decreased Ca2+ binding affinity, partial unfolding and 
destabilization. Thus, in the full-length STIM1 context, glycosylation of the EFSAM region 
enhances the activation of the molecule in response to ER Ca2+ depletion. These differences 
observed at ~0.5 mM external CaCl2 levels are consistent with a previous study using a 
similar concentration of external CaCl2 with cells expressing Asn to Gln double mutant 
STIM1 (Kilch et al., 2013).  
Interestingly, after the initial uptake at ~0.5 mM CaCl2, supplementing the external 
medium with an additional 3.5 mM CaCl2 (i.e., ~4.0 mM total external bath CaCl2) decreased 
Ca2+ influx for the wild-type mChSTIM1 compared to the single Asn131Gln or Asn171Gln 
mutant mChSTIM1. It has been known that SOCE can be regulated by extracellular Ca2+ for 
over 20 years (Petersen & Berridge, 1994), and it is well established that a fraction of STIM1 
is located on the PM with the N-terminus facing the extracellular medium (Manji et al., 
2000; Zhang et al., 2005; Lopez et al., 2006; Spassova et al., 2006). More recently, a study 
using human platelets demonstrated an extracellular Ca2+ dependent decrease in the rate of 
Mn2+ uptake through Orai1 channels at extracellular Ca2+ levels between 0 – 3 mM (Jardín et 
al., 2009). Further, this inhibition was attributed to PM localized STIM1 since external 
incubation of the cells with an antibody that recognizes STIM1 eliminated the inhibitory 
effect without cell permeabilization (Jardín et al., 2009). Thus, I speculate that the 
differences in SOCE observed at 0.5 mM and 4.0 mM extracellular Ca2+ could be driven by 
the inhibitory effects of extracellular Ca2+. The blocked glycosylation of mChSTIM1 
Asn131Gln or mChSTIM1 Asn171Gln would prevent targeting to the PM (Williams et al., 
2002) and any inhibitory effects exerted by extracellular Ca2+ on these proteins. Thus, SOCE 
mediated by the wild-type mCh-STIM1 would be inhibited by the high extracellular Ca2+, 
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while the ER-resident single and double glycosylation mutants would be unaffected, resulting 
in the significantly lower uptake of the wild-type compared to the single mutants. This 
intriguing inhibitory effect of extracellular Ca2+ may also help explain some of the 
ambiguities observed in the past glycosylation studies with single as well as double mutant 
STIM1s (Mignen et al., 2007; Csutora et al., 2008; Czyz et al., 2009; Kilch et al., 2013). 
However, we cannot rule out the possibility that suppressed SOCE was due to the mutation 
rather than blocked N-glycosylation. Thus, further investigation on the biophysical effects of 
the Gln mutation with respect to STIM1 function is needed for a more complete study. 
Nevertheless, my experiments using HEK293 cells showed that fully preventing STIM1 
luminal domain glycosylation suppresses the SOCE activity at relatively low external Ca2+ 
levels, consistent with my in vitro biophysical and structural assessments. 
 
4.4 Future studies 
My work demonstrated that glycosylation of the EFSAM domain results in increased 
protein activation and function by altering the structure such that the protein partially loses α-
helicity in the presence of Ca2+, causes destabilization and lowers Ca2+ binding affinity. 
Further, I found that blocking glycosylation in the full-length STIM1 molecules suppresses 
SOCE activation at relatively low external Ca2+ levels. While the NMR data identified 
regions of EFSAM that are structurally perturbed upon glucose attachment, solving the 3D 
structure of EFSAM in the modified state(s) would reveal precisely how the tertiary structure 
and fold of EFSAM changes in response to the modifications. This proposed structural work 
could provide new high-resolution insights into the oligomerization-prone EFSAM 
conformation, data that are currently lacking in the field. Additionally, it is important to 
assess the effects of mature glycans on the EFSAM biophysical properties and structure in 
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the singly or doubly attached scenarios. Experiments with mature glycans may reveal 
additional reasons behind the Ca2+-dependent effect on SOCE I observed in the cell culture 
experiments. 
Previous studies have found that the Asn131 and Asn171 residues on STIM1 proteins 
are glycosylated endogenously (Williams et al., 2001, 2002). However, the exact fraction of 
STIM1 proteins that is modified in this regard is unclear; moreover, the glycosylation levels 
in different tissues and cell types are unknown. Therefore, determining how partial protein 
modification affects the overall function of SOCE is another intriguing study to be performed 
to further understand the role of this cellular protein modification on SOCE. An experiment 
where incompletely modified EFSAM proteins are mixed with different percentages of 
modified EFSAMs to mimic the various scenarios in the cells would assess if modified 
EFSAM proteins can trigger unmodified EFSAM activation, and thus, an increase in SOCE 
function.  
Lastly, the SOCE pathway is heavily involved and studied in conjunction with many 
physiological diseases such as SCID, heart diseases and cancer (Roos et al., 2005; Yang et 
al., 2009; Vashisht et al., 2015; Pla et al., 2016). Since this thesis shows a role of 
glycosylation in protein activation and function, additional research on how glycosylation 
levels change in various diseases could provide important clues into the changes in SOCE 
that are involved in the manifestation of disease. For example, in certain cancers such as the 
breast cancer, it is already known that Ca2+ uptake through SOCE is increased; furthermore, 
there is increased protein glycosylation indicated by increased glycan levels in metastasizing 
breast cancer cells (Yang et al., 2009; Kölbl et al., 2015; Vashisht et al., 2015). Therefore, 
comparing the amount of endogenously glycosylated STIM1 proteins in normal and cancer 
cells would provide a mechanistic basis for the increased SOCE apart from changes in 
81 
 
protein expression patterns. Importantly, my work on the mechanisms of glycosylation-
induced enhanced STIM1 activation may lead to a new rationale for the development of 
therapeutics by modulating STIM1 function and SOCE. 
 
4.5 Overall Conclusion  
Protein modifications, such as glycosylation, are important not only for proper 
trafficking of molecules within the cell, but also for fine-tuning protein functions. Therefore, 
studying how these modifications alter the biophysical properties of proteins is crucial for 
understanding the mechanisms of function. The ER Ca2+ sensor for the SOCE pathway 
STIM1 is glycosylated at residues Asn131 and Asn171. This thesis investigated the effect of 
glucose conjugation on the biophysical properties of the Ca2+ sensing STIM1 EFSAM 
domain that mediates protein activation. Through my analysis of α-helicity, thermal stability, 
3D structure, Ca2+ binding affinity, and oligomerization, I found that glycosylation of the two 
Asn residues at the 131 and 171 residue sites of the EFSAM domain increases protein 
activation through changes in structure, Ca2+ binding affinity, oligomerization and ability to 
signal Ca2+ influx in cells (Table 4.1). Remarkably, the Asn131Cys and Asn171Cys 
mutations without any glucose conjugation promoted changes to critical Ca2+ sensing 
properties of EFSAM that were further enhanced after glucose attachment. This discovery 
indicates that even though Asn131 and Asn171 sites are at the structural periphery of 
EFSAM, these locations play important roles in the folding, structure and Ca2+ sensing 
mechanism of EFSAM.  
There are several novel aspects to this thesis research.  First, I established a site-
specific chemical approach to conjugating sugars to EFSAM and studying the structural and 
biophysical consequences of this attachment. I show that neo-glycosylation of the Asn131 
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and Asn171 sites within the vital EFSAM Ca2+ sensing domain results in structural 
perturbations that lead to modified folding, stability, Ca2+ binding affinity and 
oligomerization, properties that ultimately favor STIM1 activation. My work provides the 
first structural and mechanistic insights into how N-glycosylation effects the Ca2+ sensing 
properties of STIM1 with respect to the regulation of SOCE, and importantly, a framework 
for future studies investigating how different glycans at various stages of processing effect 
STIM1 Ca2+ sensing and SOCE activity. Collectively, my data suggests that glycosylation of 
STIM1 makes this protein more responsive to ER Ca2+ store depletion by decreasing 
foldedness, stability and Ca2+ binding affinity. Such a mechanism counteracts the 
stabilization caused by the non-conserved far N-terminal residues, making STIM1 very well 
suited as an ON/OFF activator of SOCE. Thus, modified STIM1 would be more sensitive to 
fluctuating Ca2+ levels in the ER, resulting in more fine responses to maintain ER Ca2+ levels 
at a certain concentration, while meeting the cytosolic Ca2+ demand (Figure 4.1).   
 
 
 
 
 
 
 
 
Table 4.1. Summary of the changes in EFSAM Ca2+ sensing function and SOCE activation 
due to N-glycosylation.  
✗ Glycosylation ✓ Glycosylation 
α-helicity a é ê 
Thermal stability a é ê 
Ca2+ affinity a é ê 
Oligomerization a ê é 
Ca2+ influx b ê é 
 aRecombinant EFSAM in vitro work. 
 bFull-length mChSTIM1 live cell work.  
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